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Graphical Abstract 
 
Abstract Starting from an appropriate unsaturated phenylglycinol−derived oxazolopiperidone lactam, 
the synthesis of (−)-16-episilicine is reported, the key steps being a stereoselective conjugate addition, a 
stereoselective alkylation, and a ring−closing metathesis reaction. This represents the first 





The ervatamine-silicine alkaloids1 constitute a relatively numerous group of Corynanthean-type2 2-
acylindole alkaloids with a rearranged skeleton that lacks the characteristic tryptamine moiety 
(Ind−C6−C5−N)3 present in most indole alkaloids, having an unusual Ind-C6−C16−C5−N connectivity 
instead (Figure 1).  
 
FIGURE 1. Representative alkaloids of the ervatamine-silicine group. 
Biogenetically, these alkaloids derive from secologanin via a vobasine N-oxide equivalent,2 which 
undergoes a fragmentation reaction and then a cyclization to form the central carbocyclic seven-
membered ring characteristic of these natural products (Scheme 1). As a consequence of their biogenetic 
origin, the configuration of the C-15 stereocenter in these alkaloids is usually S (H-15β),4 the same 
configuration as in C-15 in secologanin. However, they differ in the relative stereochemistry of C-16 (cis 
or trans C/D ring fusion) and C-20 (there are also C-20 E-ethylidene derivatives), the oxidation level at 
C-6 (some are 6-oxo derivatives), and the presence or not of a C-16 methoxycarbonyl group.  
SCHEME 1. Biosynthetic Pathway to Ervatamine-Silicine Alkaloids. The Absolute Configuration 




The alkaloids of the ervatamine-silicine group have received scarce attention from the synthetic 
standpoint5 and, with the exception of our preliminary report6 on the synthesis of (−)-16-episilicine, no 
enantioselective total syntheses for these alkaloids have been reported so far. 
Ervatamines and silicines can be envisaged as enantiopure 3,4,5-trisubstituted piperidines (the former 
with an additional methoxycarbonyl substituent) that embody an ethyl substituent and a seven-
membered carbocyclic ring fused on the c side of the heterocycle. 
Bearing in mind the versatility of aminoalcohol-deriv d oxazolopiperidone lactams as chiral building 
blocks for the enantioselective construction of complex piperidine-containing derivatives,7 the above 
structural features prompted us to explore the utility of these lactams as starting scaffolds for the 
synthesis of ervatamine-silicine alkaloids. Scheme 2 outlines our synthetic strategy, whose key steps 
would be i) the stereoselective conjugate addition of a vinyl residue to an unsaturated lactam already 
incorporating the ethyl substituent present in the natural targets; ii) a stereoselective alkylation t 
introduce a 2-vinyl-3-indolylmethyl fragment; and iii) a ring-closing olefin metathesis (RCM) reaction8 
to construct the carbocyclic seven-membered C ring. Subsequent oxidation-reduction and protecting-
deprotecting steps would complete the synthesis of ervatamines. The alcoxycarbonyl substituent in the 
starting lactam would not only facilitate the subsequ nt conjugate addition9 and alkylation steps but 




SCHEME 2. Synthetic Strategy 
 
Results and discussion 
The known10 lactam 1 was selected to carry out our initial studies. The conjugate addition of the vinyl 
group was accomplished in excellent chemical yield an complete xo-facial selectivity, cis with respect 
to the ethyl substituent. The subsequent alkylation of the resulting mixture of C-6 epimeric lactams 211 
with 3-(bromomethyl)indole 312 took place stereoselectively on the most accessible face of the 
piperidine ring providing derivative 4 in excellent yield (84%) as a single stereoisomer (Scheme 3). 
Surprisingly, treatment of 4 with the second−generation Grubbs catalyst in refluxing toluene led to 
hexacycle 5 (33% yield), resulting from an intramolecular Diels−Alder process,13 instead of the 
expected ring-closing metathesis product. A similar result was obtained using the Hoveyda−Grubbs 
catalyst. As might be expected, hexacycle 5 was also obtained (60% yield) when a solution of 4 in 
toluene was heated at reflux in the absence of a RCM catalyst.  




To evaluate if the failure of the ring-closing metathesis reaction could be attributed to the deactivating 
effect of the ethoxycarbonyl substituent on the vinylindole moiety, we turned our attention to diene 8, 
which bears an unsubstituted vinyl substituent on the indole ring. This diene was prepared in excellent 
overall yield by alkylation of the 1,3-dicarbonyl derivative 2 with 3-(bromomethyl)indole 6, followed by 
Wittig methylenation of the resulting 2-formylindole 7 (Scheme 4). However, heating a toluene solution 
of 8 in the presence of the second−generation Grubbs catalyst did not lead to the expected ring-closing 
metathesis product either, giving the Diels−Alder adduct 9 instead.  
SCHEME 4. Second Synthetic Approach 
 
At this point, we reasoned that the failure in the closure of the seven-membered ring of the target 
alkaloids by a RCM reaction could have a conformational origin due to the steric crowding caused by 
the benzyloxycarbonyl substituent on the quaternary c rbon. For this reason, we decided to prepare 
 
6 
diene 14a, i. e. the tert-butyl ester analog of 8, from which the tert-butoxycarbonyl group could be 
easily removed under non-reductive conditions withou  affecting the carbon-carbon double bonds. The 
synthesis of 14a was performed as outlined in Scheme 5, following a synthetic route similar to that 
previously developed in the above benzyloxycarbonyl series but starting from the unsaturated lactam 
11a. This was readily accessible by sequential treatmen  of lactam 10a14 with (TMS)2NLi, di-tert-butyl 
dicarbonate, and PhSeCl, followed by oxidation of the resulting mixture of selenides. Both the conjugate 
addition of the vinyl residue and the alkylation of the resulting lactam 12a11 (mixture of C-6 epimers) 
took place in excellent chemical yield and complete stereoselectivity. A subsequent Wittig 
methylenation of 2-formylindole 13a led to the new key intermediate 14a. 
SCHEME 5. Third Synthetic Approach 
 
Removal of the C-6 tert-butoxycarbonyl group from 14a was accomplished by treatment with TFA 
followed by heating of the resulting keto acid in refluxing toluene to give 6,7-trans oxazolopiperidone 
15a in 81% yield. Only trace amounts of the corresponding 6-epimer were detected.  
Gratifyingly, as we had assumed, diene 15a underwent a ring-closing metathesis reaction on treatment 
with the second–generation Grubbs catalyst in refluxing toluene, leading to the desired pentacycle 16a 
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in 86% yield. The absolute configuration of 16a was unambiguously established by X-ray 
crystallographic analysis (Figure 2), thus confirming both the stereochemical outcome of the conjugate 





FIGURE 2. X-ray crystal structure of pentacycles 16a and 16b. 
In fact, the conjugate addition of organocuprates to unsaturated oxazolopiperidone lactams is highly 
stereoselective15 as a consequence of the conformational rigidity of the bicyclic system, occurring under 
stereoelectronic control,16 axial to the electrophilic carbon of the conjugate double bond and, 
consequently, cis with respect to the adjacent pseudoequatorial ethyl substituent (see 11a in Scheme 6). 
To obtain the natural (H-15β) absolute configuration at C-15, an obvious solutin was to start from the 
enantiomeric lactam ent-11a, which would be accessible from the S-phenylglycinol-derived lactam ent-
10a. However, taking into account the availability of lactam 10b,17 to access the natural C-15 absolute 
configuration we decided to use the unsaturated lactam 11b, which presumably would also undergo a 
stereoselective conjugate addition ultimately leading to H-15β isomers. This lactam incorporates a C-8 
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ethyl substituent with the absolute configuration required for the synthesis of 16-episilicine, an alkaloid 
isolated in 1975 from Pandaca caducifolia.18 
SCHEME 6. Control of the C-15 Configuration 
 
The synthetic sequence for the preparation of the key intermediate 16b starting from lactam 10b is 
outlined in Scheme 7 and parallels that previously developed starting from the diastereoisomeric lactam 
10a. As expected, the conjugate addition of the vinyl group to the unsaturated lactam 11b took place 
stereoselectively leading to the exo isomer 12b (mixture of C-6 epimers). A subsequent alkylation with 
the N-protected indole derivative 6 afforded 13b in 75% yield as a single stereoisomer, thus confirming 
the facial stereoselectivity of the conjugate addition reaction. Witttig methylenation of 13b followed by 
removal of the tert-butoxycarbonyl group gave diene 15b in 58% overall yield. Minor amounts (10%) of 
the C-6 epimer (6-epi-15b) were also isolated. The crucial ring−closing metathesis of 15b was 
efficiently performed using the second−generation Grubbs catalyst under refluxing toluene to give the 
trans-fused pentacycle 16b in 87% yield. Quite unexpectedly, a similar treatment from 6-epi-15b led to 
the anticipated cis-fused pentacycle 16-epi-16b in only 24% yield, the main  product (50%) being the 
Diels−Alder adduct 21 (Scheme 8). As in the failure of the RCM reactions from dienes 4 and 8, the 
different behavior of 15b and 6-epi-15b under RCM reaction conditions can most probably be explained 
on conformational grounds. The absolute configuration of 16b (Figure 2), coinciding at C−15 with the 
 
9 
natural configuration (15β-H), and 21 were unambiguously established by X-ray crystallographic 
analysis. 



































































































SCHEME 8. RCM Reaction from Diene 6-epi-15b 
 
Once the tetracyclic ring system of the target alkaloid, with the required trans-C15−C16 and cis-C15−C20 
configuration, was assembled, to complete the synthesis from 16b we only needed to remove the chiral 
auxiliary and the indole protecting group, and to adjust the oxidation level. Catalytic hydrogenation of 
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the carbon-carbon double bond of 16b followed by treatment with LiAlH4-AlCl3, which brought about 
both the reduction of the lactam carbonyl group and the reductive opening of the oxazolidine ring, gave 
tetracycle 17 in 64% overall yield. Deprotection of the indole nitrogen under smooth conditions, 
followed by a catalytic debenzylation in the presence of (Boc)2O led to the N-Boc protected piperidine 
derivative 19. A chemoselective oxidation with I2O5
19 installed the 2-acylindole carbonyl group. Finally, 
removal of the Boc protecting group followed by methylation furnished (−)-16-episilicine, thus 
completing the first synthesis of this natural product.  
The 1H and 13C NMR data of our synthetic 16-episilicine were in complete agreement with those 
previously reported18b for the alkaloid. However, the specific rotation of our synthetic material {[α]D22 
−20, c 1.0, CHCl3)}, although coinciding in its absolute value with at reported for 16-episilicine 
{[ α]D22 +20, c 1.0, CHCl3)}, 18 had the opposite sign.20 Taking into account that the C-15 configuration 
(S, 15β-H) of our synthetic 16-episilicine stems from the X-ray crystallographic analysis of the 
advanced intermediate 16b, the discrepancy in the sign of the [α]D values is striking since it might point 
to an uncommon 15α-H absolute configuration for the alkaloid 16-episilicine, which would be the 
enantiomer of the structure depicted in Figure 1. Hovewer, this would need to be confirmed with new 
material isolated from natural sources. 
Conclusion 
In summary, we have accomplished for the first time the enantioselective total synthesis of an alkaloid 
of the silicine group, thus further illustrating the potential and versatility of phenylglycinol–derived 
oxazolopiperidone lactams in the synthesis of enantiopure piperidine–containing complex natural 
products. The unexpected behavior of dienes 4 and 8 under RCM reaction conditions represents a 








oxazolo[3,2-a]pyridine (2). LiCl (906 mg, 21.3 mmol) was heated at 80 ºC for 3 h under vacuum (10-
15 mm Hg) in a three-necked 500 mL round-bottomed flask. Then, CuI (5.6 g, 29.1 mmol) and THF (40 
mL) were added at room temperature, and the mixture was stirred at rt for 5 min. The suspension was 
cooled at –78 ºC, and vinylmagnesium bromide (1 M in THF, 29 mL), TMSCl (3.7 mL, 29.1 mmol), 
and a solution of the crude unsaturated lactam 110 (2.88 g) in THF (100 mL) were successively added. 
The resulting mixture was stirred at –78 ºC for 23 h. The reaction was quenched with saturated aqueous 
NH4Cl, and the aqueous layer was extracted with EtOAc. The combined organic extracts were dried and 
concentrated. Flash chromatography (4:1 hexane–EtOAc to 1:1 hexane–EtOAc) gave  lactams 2 and 6-
epi-2 as a 4:1 mixture (2.80 g, 90% yield from the crude nsaturated lactam 1). 2 (major epimer): IR 
(NaCl) 1664, 1735 cm–1; 1H NMR (CDCl3, 400 MHz, COSY, HETCOR) δ 0.99 (t, J = 7.3 Hz, 3H, CH3 
ethyl), 1.36-1.46 (m, 1H, CH2 ethyl), 1.74-1.87 (m, 1H, CH2 ethyl), 2.24-2.31 (m, 1H, H-8), 3.02 (dd, J 
= 7.6, 3.6 Hz, 1H, H-7), 3.50 (d, J = 1.2 Hz, 1H, H-6), 3.99 (dd, J = 9.2, 1.2 Hz, 1H, H-2), 4.12 (dd, J = 
9.2, 7.2 Hz, 1H, H-2), 4.55 (d, J = 10.0 Hz, 1H, H-8a), 4.91-4.95 (m, 1H, H-3), 5.02-5. 6 (m, 4H, 
CH2C6H5, CH2=), 5.83 (ddd, J = 17.2, 10.4, 7.6  Hz, 1H, CH=), 7.19-7.35 (m, 10H, ArH); 
13C NMR 
(CDCl3, 100.6 MHz) δ 10.9 (CH3 ethyl), 20.5 (CH2 ethyl), 40.4 (C-7), 41.0 (C-8), 52.5 (C-6), 59.4 (C-
3), 67.0 (CH2C6H5), 73.9 (C-2), 90.1 (C-8a), 118.2 (CH=), 126.4 (C-o), 127.4 (C-m), 128.0 (C-p), 128.2 
(C-o), 128.4 (C-m), 128.5 (C-p), 134.1 (CH2=), 140.6 (C-i), 162.0 (NCO), 169.7 (CO); 6-epi-2 (minor 
epimer): IR (NaCl) 1664, 1735 cm–1; 1H NMR (400 MHz, CDCl3, COSY, HETCOR) δ 1.04 (t, J = 7.4 
Hz, 3H, CH3 ethyl), 1.36-1.46 (m, 1H, CH2 ethyl), 1.74-1.87 (m, 1H, CH2 ethyl), 2.24-2.31 (m, 1H, H-
8), 3.11 (ddd, J = 10.4, 6.4, 4.0 Hz, 1H, H-7), 3.56 (d, J = 6.4 Hz, 1H, H-6), 4.05 (dd, J = 9.2, 1.2 Hz, 
1H, H-2), 4.13 (dd, J = 9.2, 7.2 Hz, 1H, H-2), 4.67 (d, J = 9.6 Hz, 1H, H-8a), 4.91-4.95 (m, 1H, H-3), 
5.02-5.26 (m, 4H, CH2C6H5, CH2=), 5.73 (dt, J = 16.4, 10.8 Hz, 1H, CH=), 7.19-7.35 (m, 10H, ArH); 
13C NMR (CDCl3, 100.6 MHz) δ 10.9 (CH3 ethyl), 20.9 (CH2 ethyl), 42.6 (C-7), 44.4 (C-8), 53.9 (C-6), 
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59.7 (C-3), 66.8 (CH2C6H5), 73.7 (C-2), 89.5 (C-8a), 120.1 (CH2=), 126.4 (C-o), 127.4 (C-m), 128.0 (C-
p), 128.2 (C-o), 128.4 (C-m), 128.5 (C-p), 132.4 (CH=), 135.4 (C-i), 162.3 (NCO), 168.4 (COO); 
HRMS calcd for [C25H27NO4 + Na]: 428.1832, found: 428.1837. 
(3R,6R,7R,8S,8aR)-6-[(1-Benzenesulfonyl-2-(E-ethoxycarbonyl)vinyl-3-indolyl)methyl]-6-
(benzyloxycarbonyl)-8-ethyl-5-oxo-3-phenyl-7-vinyl-2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-
a]pyridine (4). NaH (60% dispersion in mineral oil, 60 mg, 1.51 mmol) was slowly added at 0 ºC to a 
solution of lactams 2 (513 mg, 1.26 mmol) in dry DMF (18 mL), and the mixture was stirred at 0ºC for 
1 h. Then, a solution of bromomethylindole 312 (850 mg, 1.9 mmol) in DMF (6 mL) was added at 0°C, 
and the resulting mixture was stirred at room temperature for 24 h. The mixture was poured into water, 
the aqueous layer was extracted with Et2O, and the combined organic extracts were dried and 
concentrated. Flash chromatography of the resulting oil (9:1 hexane–EtOAc to 1:1 hexane–EtOAc) 
afforded pure compound 4 (820 mg, 84% yield): IR (film) 1659, 1715 cm–1; 1H NMR (400 MHz, 
CDCl3, COSY, HETCOR) δ 0.72 (t, J = 7.2 Hz, 3H, CH3 ethyl), 1.12-1.18 (m, 2H, CH2 ethyl, H-8), 1.37 
(t, J = 7.2 Hz, 3H, CH3CH2CO), 1.48-1.54 (m, 1H, CH2 ethyl), 2.94 (dd, J = 10.8, 4.4 Hz, 1H, H-7), 
3.56 (d, J = 14.8 Hz, 1H, CH2-ind), 3.66 (d, J = 14.8 Hz, 1H, CH2-ind), 3.92 (dd, J = 9.0, 1.2 Hz, 1H, H-
2), 4.00 (dd, J = 9.0, 6.5 Hz, 1H, H-2), 4.28-4.36 (m, 2H, CH3CH2CO),  4.62 (d, J = 9.2 Hz, 1H, H-8a), 
4.82 (d, J = 6.5 Hz, 1H, H-3), 4.92-5.03 (m, 4H, CH2C6H5, HC=CH2), 5.57-5.67 (m, 1H, HC=CH2), 
6.26 (d, J = 16.4 Hz, 1 H, CH=CHCO), 6.69 (m, 1H, H-6 ind), 7.06-7.46 (m, 11H, ArH, -5 ind), 7.65 
(dd, J = 8.4, 1.2 Hz, 1H, H-7 ind), 8.05 (d, J = 16.4 Hz, 1H, CH=CHCO), 8.11 (d, J = 8.4 Hz, 1H, H-4 
ind); 13C NMR (CDCl3, 100.6 MHz) δ 10.5 (CH3 ethyl), 14.3 (CH3CH2CO), 20.1 (CH2 ethyl), 29.7 
(CH2-ind), 43.4 (C-8), 46.0 (C-7), 59.9 (C-6), 60.2 (C-3), 60.8 (CH3CH2CO), 67.1 (CH2C6H5), 74.2 (C-
2), 88.7 (C-8a), 114.2 (CH=CHCO), 120.1 (HC=CH2), 121.4 (C-7 ind), 121.7 (C-4 ind), 124.6 (C-3 
ind), 124.9 (CH=CHCO), 126.0 (C-2 ind), 126.7 (C-6 ind), 126.9 (C-5 ind), 127.5 (C-o), 128.1 (C-m), 
128.2 (C-p), 128.5 (C-o), 128.6 (C-m), 129.0 (C-p), 130.4 (C-i), 132.9 (HC=CH2), 133.9 (C-i), 135.0 
(C-i), 135.2 (C-o), 136.3 (C-m), 137.9 (C-3a ind), 140.9 (C-7a ind), 165.8 (COO), 165.9 (COO), 170.4 
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(NCO); [α]22D  –58.3 (c 1.0, CHCl3). Anal. Calcd. for  C45H44N2O8S: C, 69.93; H, 5.74; N, 3.62; S, 4.15. 
Found: C, 69.93; H, 5.69; N, 3.55; S, 4.05. 
Attempted RCM reaction from 4.  Second−generation Grubbs catalyst (2 mg) was added to a solution 
of compound 4 (60 mg, 0.08 mmol) in toluene (20 mL) and the resulting mixture was heated at reflux 
for 16 days, with an additional 2 mg of catalyst being added each 24h. The solvent was evaporated and 
the resulting residue was chromatographed (99:1 CH2Cl2–EtOAc) to yield hexacycle 5 (20 mg, 33% 
yield): IR (film): 1678, 1730 cm–1; 1H NMR (400 MHz, CDCl3, COSY, HETCOR; see Supporting 
Information for the numbering system) δ 0.99 (t, J = 7.4 Hz, 3H, CH3 ethyl), 1.31 (t, J = 7.1 Hz, 3H, 
CH3CH2CO), 1.36 (d, J = 15.6 Hz, 1H, H-15), 1.65 (d, J = 15.6 Hz, 1H, H-15), 1.79-1.87 (m, 1H, H-8), 
1.89-1.99 (m, 2H, CH2 ethyl), 2.13-2.19 (m, 1H,  H-10), 2.46-2.53 (m, 2H, H-8a, H-9), 2.96-3.01 (m, 
1H, H-7), 3.08 (dd, J = 9.6, 4.8 Hz, 1H, H-8b), 4.07 (d, J = 4.0 Hz, 2H, H-11), 4.17 (d, J = 6.4 Hz, 1H, 
CH3CH2CO), 4.21 (d, J = 6.4 Hz, 1H, CH3CH2CO), 4.77 (t, J = 4.0 Hz, 1H, H-12), 4.88 (d, J = 6.0 Hz, 
1H, H-9a), 5.06 (d, J = 12.0 Hz, 1H, CH2C6H5), 5.16 (d, J = 12.0 Hz, 1H, CH2C6H5), 6.38 (d, J = 3.6 
Hz, 1H, H-6), 6.56 (d, J = 7.6 Hz, 1H, H-1), 6.75 (ddd, J = 8.8, 7.6, 1.2 Hz, 1H, H-2), 7.11 (dd, J = 8.4, 
1.2 Hz, 1H, ArH), 7.16 (dd, J = 8.4, 1.2 Hz, 1H, ArH), 7.32-7.44 (m, 13H, ArH), 7.50 (dd,    J = 8.8, 1.2 
Hz, 1H, H-4), 7.77 (dd, J = 8.8, 0.8 Hz, 1H, H-3); 13C NMR (CDCl3, 100.6 MHz) δ 12.9 (CH3 ethyl), 
14.2 (CH3CH2CO), 24.3 (CH2 ethyl), 25.2 (C-8), 39.7 (C-7), 43.0 (C-9), 43.8 (C-8a), 44.0 (C-15), 49.7 
(C-8b), 53.2 (C-15a), 58.1 (C-12), 60.3 (C-14a), 61.1 (CH3CH2CO), 67.7 (CH2C6H5), 74.1 (C-11), 93.5 
(C-9a), 110.0 (C-6), 113.0 (C-4), 116.9 (C-2), 121.8 (C-3), 125.5 (C-1), 126.4 (C-o), 126.9 (C-m), 127.8 
(C-p), 128.0 (C-o), 128.6 (C-m), 128.7 (C-p), 128.8 (C-o), 128.9 (C-m), 133.6 (C-i), 134.9 (C-i), 137.0 
(C-i), 138.8 (C-15b), 140.2 (C-4a), 141.6 (C-5a), 144.4 (C-6), 166.0 (NCO), 170.8 (COO), 173.2 
(COO);  [α]22D  –56.1 (c 0,5, CHCl3). Anal. Calcd. for C45H44N2O8S: C, 69.93; H, 5.74; N, 3.62; S, 4.15. 
Found: C, 69.81; H, 5.76; N, 3.29; S, 3.89.  
1-(Benzenesulfonyl)-3-(bromomethyl)indole-2-carbaldehyde (6). Benzoyl peroxide (2 mg (0.008 
mmol) was added at rt to a solution of 1-(benzenesulfonyl)-3-methylindole-2-carbaldehyde21 (250 mg, 
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0.84 mmol) and NBS (155 mg, 0.87 mmol) in anhydrous CCl4 (20 mL). The mixture was heated at 
reflux for 4 h, cooled at rt, and filtered. The solution was concentrated, and the resulting residue was 
chromatographed (hexane to 9:1 hexane−EtOAc) to give formylindole 6 (188 mg, 60% yield): IR (film) 
1678 cm–1; 1H NMR (300 MHz, CDCl3) δ 4.91 (s, 2H, CH2), 7.39-7.74 (m, 8H, ArH), 8.22 (d, J = 8.7 
Hz, 1H, H-4), 10.66 (s, 1H, CHO); 13C NMR (CDCl3, 75.4 MHz) δ 20.6 (CH2), 115.6 (C-7), 121.6 (C-
4), 125.1 (C-6), 126.6 (C-5), 128.1 (C-3), 129.4 (C-o), 129.5 (C-m), 129.7 (C-p), 132.3 (C-2), 134.5 (C-
3a), 137.1 (C-7a), 137.2 (C-i), 184.8 (CHO); HRMS calcd for [C16H12NO3SBr + H]: 377.9794, found: 
377.9781. 
(3R,6R,7R,8S,8aR)-6-[(1-Benzenesulfonyl-2-formyl-3-indolyl)methyl]-6-(benzyloxycarbonyl)-8-
ethyl-5-oxo-3-phenyl-7-vinyl-2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine (7). Operating as in 
the above preparation of 4, from lactam 2 (39 mg, 0.1 mmol), NaH (60% dispersion in mineral oil, 4.8 
mg, 0.12 mmol), and bromomethylindole 6 (63 mg, 0.16 mmol) in DMF (2 mL), compound 7 (51 mg, 
75% yield) was obtained after column chromatography (9:1 hexane–EtOAc to 1:1 hexane–EtOAc) as a 
yellow foam: IR (film): 1661, 1735 cm–1; 1H NMR (400 MHz, CDCl3, COSY, HETCOR) δ 0.88 (t, J = 
7.6 Hz, 3H, CH3 ethyl), 1.26-1.31 (m, 1H, CH2 ethyl), 1.61-1.69 (m, 2H, CH2 ethyl, H-8), 3.62 (dd, J = 
10.8, 4.4 Hz, 1H, H-7), 3.74 (d, J = 14.0 Hz, 1H, CH2-ind), 3.78 (d, J = 14.0 Hz, 1H, CH2-ind), 3.87 (d, 
J = 9.2 Hz, 1H, H-2), 4.03 (dd, J = 9.2, 7.2 Hz, 1H, H-2), 4.67 (d, J = 9.2 Hz, 1H, H-8a), 4.81 (d, J = 6.0 
Hz, 1H, H-3), 4.95 (d, J = 12.4 Hz, 1H, CH2C6H5), 5.00 (d, J = 12.4 Hz, 1H, CH2C6H5), 5.04 (dd, J = 
10.0, 1.6 Hz, 1H, HC=CH2), 5.27 (dd, J = 16.0, 1.6 Hz, 1H, HC=CH2), 5.68 (dt, J = 16.0, 10.0 Hz, 1H, 
HC=CH2), 6.73 (t, J = 8.0 Hz, 1 H, H-5 ind), 6.87 (d, J = 4.4 Hz, 1 H, ArH), 7.05-7.08 (m, 1H, H-6 ind), 
7.24-7.52 (m, 14H, ArH), 7.73 (dd, J = 8.0, 1.6 Hz, 1H,  H-7 ind), 7.98 (d, J = 8.0 Hz, 1H, H-4 ind), 
10.29 (s, 1H, CHO); 13C NMR (CDCl3, 100.6 MHz) δ 10.6 (CH3 ethyl), 20.6 (CH2 ethyl), 31.3 (CH2-
ind), 42.2 (C-8), 46.1 (C-7), 60.2 (C-6), 60.3 (C-3), 67.1 (CH2C6H5), 74.3 (C-2), 89.1 (C-8a), 114.3 (C-7 
ind), 120.0 (HC=CH2), 120.3 (C-6 ind), 123.9 (C-5 ind), 128.4 (C-4 ind), 126.6 (C-3 ind), 126.7 (C-o), 
127.4 (C-m), 128.1 (C-p), 128.2 (C-o), 128.4 (C-m), 128.8 (C-p), 129.4 (HC=CH2), 130.8 (C-o), 133.2 
 
15 
(C-m), 134.1 (C-3a ind), 135.0 (C-i), 135.3 (C-i), 137.1 (C-i), 137.8 (C-2 ind), 140.1 (C-7a ind), 165.5 
(COO), 170.6 (NCO), 183.9 (CHO); [α]22D –27.7 (c 0.3, CHCl3). Anal. Calcd. for 
C41H38N2O7S
.1/2CH2Cl2: C, 66.88; H, 5.27; N, 3.76; S, 4.30. Found: C, 66.88; H, 5.29; N, 3.85; S, 4.31. 
(3R,6R,7R,8S,8aR)-6-[(1-Benzenesulfonyl-2-vinyl-3-indolyl)methyl]-6-(benzyloxycarbonyl)-8-
ethyl- 5-oxo-3-phenyl-7-vinyl-2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine (8). KHMDS (0.5 
M in toluene, 2.16 mL, 1.08 mmol) was added to a solution of methyltriphenylphosphonium bromide 
(387 mg, 1.08 mmol) in anhydrous THF, and the mixture was stirred at rt for 30 min. This solution was 
slowy transferred to a solution of formylindole 7 (370 mg, 0.53 mmol) in anhydrous THF (20 mL), and 
the mixture was heated at reflux for 4 h. The reaction was quenched by addition of water, and the 
mixture was extracted with Et2O. The combined organic extracts were dried and concentrated. Flash 
chromatography (9:1 hexane–CH2Cl2 to 1:1 hexane–CH2Cl2) gave 8 (323 mg, 87% yield): IR (film) 
1658, 1740 cm–1; 1H NMR (400 MHz, CDCl3, COSY, HETCOR) δ 0.56 (t, J = 7.2 Hz, 3H, CH3 ethyl), 
1.08-1.20 (m, 2H, CH2 ethyl, H-8), 1.47-1.55 (m, 1H, CH2 ethyl), 2.98 (dd, J = 10.8, 4.4 Hz, 1H, H-7), 
3.55 (d, J = 15.2 Hz, 1H, CH2-ind), 3.71 (d, J = 15.2 Hz, 1H, CH2-ind), 3.97 (dd, J = 9.2, 1.6 Hz, 1H, H-
2), 4.01 (dd, J = 9.2, 6.4 Hz, 1H, H-2), 4.61 (d, J = 9.6 Hz, 1H, H-8a), 4.84 (dd, J = 6.4, 1.6 Hz, 1H, H-
3), 4.94 (d,  J = 12.4 Hz, 1H, CH2C6H5), 4.95 (dt, J = 8.0, 1.6 Hz, 1H, CH=CH2), 5.00 (d, J = 1.6 Hz, 
1H, CH=CH2), 5.05 (d, J = 12.4 Hz, 1H, CH2C6H5), 5.37 (dd, J = 17.0, 1.6 Hz, 1H, ind-HC=CH2), 5.51 
(dd, J = 11.0, 1.6 Hz, 1H, ind-HC=CH2), 5.63 (dd, J = 17.0, 11.0 Hz, 1H, ind-HC=CH2), 6.80 (td, J = 
8.0, 0.8 Hz, 1 H, CH=CH2), 6.80 (td, J = 7.6, 0.8 Hz, 1H, H-5 ind), 6.85 (d, J = 11.6 Hz, 1 H, ArH), 6.88 
(d, J = 11.6 Hz, 1 H, ArH), 7.16-7.38 (m, 13H, ArH), 7.45 (tt, J = 7.6, 1.2 Hz, 1H, H-6 ind), 7.70-7.73 
(m, 1H, H-7 ind), 8.11 (dd, J = 7.6, 0.4 Hz, 1H, H-4 ind); 13C NMR (CDCl3, 100.6 MHz) δ 10.3 (CH3 
ethyl), 20.0 (CH2 ethyl), 28.9 (CH2-ind), 43.2 (C-8), 45.1 (C-7), 60.1 (C-3), 60.2 (C-6), 67.0 (CH2C6H5), 
74.2 (C-2), 88.7 (C-8a), 114.0 (C-7 ind), 117.2 (C-5 ind), 119.7 (CH=CH2), 120.9 (C-6 ind), 122.7 (ind-
CH=CH2), 124.1 (ind-CH=CH2), 124.9 (C-3 ind), 126.8 (C-4 ind), 127.2 (CH=CH2), 127.5 (C-o), 128.0 
(C-m), 128.1 (C-p), 128.2 (C-o), 128.5 (C-m), 128.6 (C-p), 128.9 (C-o), 130.8 (C-3a ind), 133.3 (C-m), 
133.6 (C-p), 135.3 (C-i), 135.4 (C-2 ind), 137.1 (C-i), 138.4 (C-i), 140.9 (C-7a ind), 166.3 (COO), 170.9 
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(NCO); [α]22D  –21.5 (c 0.4, CHCl3). Anal. Calcd. For C42H40N2O6S.1/2H2O: C, 67.63; H, 6.08; N, 3.76. 
Found C, 67.40; H, 5.68; N, 3.56. 
Attempted RCM reaction from 8.  Operating as in the preparation of compound 5, hexacycle 9 was 
obtained (8 mg, 32% yield) from lactam 8 (25 mg, 0.04 mmol) and the second−generation Grubbs 
catalyst (8 mg; 0.5 mg/day, 16 days) in toluene (10 mL) after flash chromatography (9:1 CH2Cl2–
EtOAc). 9: IR (film) 1661, 1730 cm–1; 1H NMR (400 MHz, CDCl3, COSY, HETCOR; see Supporting 
Information for the numbering system) δ 0.84 (t, J = 7.3 Hz, 3H, CH3 ethyl), 1.42-1.78 (m, 6H, CH2 
ethyl, H-7, H-8), 2.20-2.25 (m, 1H, H-9), 2.55 (d, J = 16.0 Hz, 1H, H-15), 2.75 (d, J = 16.0 Hz, 1H, H-
15), 2.97 (dd, J = 8.8, 4.8 Hz, 1H, H-8b), 3.06 (m, 1H, H-8a), 4.07 (d, J = 4.0 Hz, 2H, H-11), 4.88 (t, J = 
4.0 Hz, 1H, H-12), 4.93 (d, J = 5.6 Hz, 1H, H-9a), 5.18 (d, J = 12.0 Hz, 1H, CH2C6H5), 5.23 (d, J = 12.0 
Hz, 1H, CH2C6H5), 6.27 (d, J = 7.6 Hz, 1H, H-6), 6.56 (td, J = 8.0, 0.8 Hz, 1H, H-1), 7.11 (td, J = 8.0, 
1.2 Hz, 1H, H-2), 7.36-7.45 (m, 15H, ArH), 7.56 (d,J = 7.6 Hz, 1H, H-4),  8.00 (dd, J = 8.0, 1.6 Hz, 1H, 
H-3); 13C NMR (CDCl3, 100.6 MHz) δ 12.5 (CH3 ethyl), 24.7 (CH2 ethyl), 21.6 (C-8), 23.6 (C-7), 32.8 
(C-15), 42.1 (C-9), 47.6 (C-8a), 49.9 (C-8b), 58.1 (C-12), 59.3 (C-15a), 60.2 (C-14a), 67.9 (CH2C6H5), 
74.0 (C-11), 93.7 (C-9a), 101.8 (C-6), 114.5 (C-4), 117.0 (C-2), 123.1 (C-3), 124.7 (C-1), 126.7 (C-o), 
127.1 (C-m), 127.7 (C-p), 128.0 (C-o), 128.2 (C-m), 128.7 (C-p), 134.7 (C-i), 137.1 (C-i), 139.2 (C-
15b), 140.2 (C-4b), 141.8 (C-5a), 167.7 (COO), 172.2 (NCO);  [α]22D  +14.6 (c 0.5, CHCl3); HRMS 
calcd for [C42H40N2O6S + H]: 701.8509, found, 701,8504. 
(3R,8S,8aR)-6-(tert-Butoxycarbonyl)-8-ethyl-5-oxo-3-phenyl-2,3,8,8a-terahydro-5H-oxazolo[3,2-
a]pyridine (11a). Lithium bis(trimethylsilyl)amide (17.4 mL of a 1.0 M solution in THF) was slowly 
added at −78 ºC to a solution of lactam 10a14 (2 g, 8.1 mmol) in anhydrous THF (100 mL), and the
resulting mixture was stirred for 90 min. Then, (Boc)2O (1.90 g, 8.71 mmol) and, after 2 h of continuous 
stirring at −78 ºC, a solution of PhSeCl (2.12 g, 11.05 mmol) in anhydrous THF (10 mL) were added. 
The mixture was stirred for 2 h and poured into saturated aqueous NH4Cl. The aqueous layer was 
extracted with EtOAc, and the combined organic extracts were dried and concentrated. Flash 
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chromatography (1:9 hexane–EtOAc) of the resulting oil afforded the corresponding selenides as a 
mixture of C-6 epimers (3.64 g, 89 % yield). Pure isomers were isolated after a subsequent 
chromatography. Higher Rf epimer: IR (NaCl) 1665, 1726 cm
–1; 1H NMR (CDCl3, 400 MHz, COSY, 
HETCOR) δ 0.91 (t, J = 7.2 Hz, 3H, CH3), 1.18 (m, 1H, CH2 ethyl), 1.29 [s, 9H, (CH3)3C], 1.66 (m, 1H, 
CH2 ethyl), 1.76 (t,  J = 12.4 Hz, 1H, H-7), 1.81 (m, 1H, H-8), 2.36 (dd, J = 12.4, 1.2 Hz, 1H, H-7), 3.88 
(d, J = 8.8 Hz, 1H, H-8a), 3.95 (dd, J = 9.2, 6.8 Hz, 1H, H-2), 3.98 (dd, J = 9.2, 2.4 Hz, 1H, H-2), 4.81 
(dd, J = 6.8, 2.4 Hz, 1H, H-3), 7.20-7.55 (m, 10H, ArH); 13C NMR (CDCl3, 100.6 MHz) δ 10.6 (CH3), 
23.4 (CH2 ethyl), 27.5 [(CH3)3C], 36.8 (C-7), 39.8 (C-8), 55.7 (C-6), 59.2 (C-3), 74.0 (C-2), 82.7 
[(CH3)3C], 92.2 (C-8a), 126.9-129.5 (C-o, m, p), 138.3 (C-i), 140.8 (C-i), 163.6 (NCO), 168.9 (COO); 
HRMS calcd for [C26H31NO4Se + H]: 502.1484, found: 502.1491. Lower Rf epimer: IR (NaCl) 1668, 
1725 cm–1; 1H NMR (CDCl3, 400 MHz, COSY, HETCOR) δ 0.91 (t, J = 7.2 Hz, 3H, CH3), 1.18 (m, 
1H, CH2 ethyl), 1.45 [s, 9H, (CH3)3C)], 1.66 (m, 1H, CH2 ethyl), 1.96 (dd, J = 14.0, 11.2 Hz, 1H, H-7), 
2.04 (m, 1H, H-8), 2.13 (dd, J = 14.0, 3.6 Hz, 1H, H-7), 4.06 (dd, J = 9.2, 1.2 Hz, 1H, H-2), 4.16 (dd, J 
= 9.2, 6.8 Hz, 1H, H-2), 4.57 (d, J = 8.4 Hz, 1H, H-8a), 4.95 (dd, J = 6.8, 1.2 Hz, 1H, H-3), 7.20-7.55 
(m, 10H, ArH); 13C NMR (CDCl3, 100.6 MHz) δ 10.8 (CH3), 23.9 (CH2 ethyl), 27.8 [(CH3)3C], 34.3 (C-
7), 38.5 (C-8), 56.7 (C-6), 59.3 (C-3), 73.9 (C-2), 82.8 [(CH3)3C], 92.1 (C-8a), 126.7-129.5 (C-o, m, p), 
138.1 (C-i), 140.7 (C-i), 163.5 (NCO), 168.6 (COO); HRMS calcd for [C52H62N2O8Se2 + Na]: 
1025.2728, found: 1025.2732. A stream of ozone gas was bubbled through a cooled (−78 ºC) solution of 
the above selenides (3.64 g, 7.26 mmol) in anhydrous CH2Cl2 (215 mL) until it turned pale blue (5 min). 
Then, the solution was purged with O2, and the temperature was slowly raised to 25 ºC. After 30 min of 
stirring, the mixture was poured intro brine, and the aqueous layer was extracted with CH2 l2. The 
combined organic extracts were dried and concentrated to give unsaturated lactam 11a (2.5 g) as an oil, 
which due to its unstability was used in the next raction without further purification: 1H NMR (CDCl3, 
300 MHz) δ 1.14 (t, J = 7.5 Hz, 3H, CH3), 1.50 [s, 9H, C(CH3)3], 1.64 (m, 1H, CH2 ethyl), 1.88 (m, 1H, 
CH2 ethyl), 2.72 (m, 1H, H-8), 4.14 (dd, J = 8.7, 1.5 Hz, 1H, H-2), 4.21 (dd, J = 8.7, 6.3 Hz, 1H, H-2), 
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4.85 (d, J = 10.5 Hz, 1H, H-8a), 5.05 (dd, J = 6.3, 1.5 Hz, 1H, H-3), 7.03 (d, J = 1.4 Hz, 1H, H-7), 7.10-
7.20 (m, 5H, ArH). 
(3R,8R,8aS)-6-(tert-Butoxycarbonyl)-8-ethyl-5-oxo-3-phenyl-2,3,8,8a-terahydro-5H-oxazolo[3,2-
a]pyridine (11b).  Operating as in the above preparation of 11a, from lactam 10b17 (1.56 g, 6.36 mmol) 
in THF (100 mL), LiHMDS (13.5 mL of a 1.0 M solution in THF), (Boc)2O (1.47 g, 6.74 mmol) in THF 
(20 ml), and PhSeCl (1.64 g, 8.54 mmol) in THF (10 mL), a 7:3 mixture of C-6 epimeric selenides (2.6 
g,  82% yield) was obtained. Pure isomers were isolated after a subsequent flash chromatography (9:1 
hexane−EtOAc to 4:1 hexane−EtOAc). Higher Rf epimer: IR (NaCl) 1658, 1735 cm–1; 1H NMR (CDCl3, 
400 MHz, COSY, HETCOR) δ 0.73 (t, J = 7.3 Hz, 3H, CH3 ethyl), 1.12-1.20 (m, 1H, CH2 ethyl), 1.44 
[s, 9H, C(CH3)3], 1.64-1.71 (m, 1H, CH2 ethyl), 1.83-1.92 (m, 2H, H-7, H-8), 2.03 (dd, J = 11.2, 2.0 Hz, 
1H, H-7), 3.73 (dd, J = 8.8, 0.4 Hz, 1H, H-2), 4.44 (dd, J = 8.8, 7.6 Hz, 1H, H-2), 4.67 (d, J = 8.0 Hz, 
1H, H-8a), 5.25 (t, J = 7.6 Hz, 1H, H-3), 7.24-7.40 (m, 8H, ArH), 7.80 (m, 2H, Ar-H); 13C NMR 
(CDCl3, 100.6 MHz) δ 10.8 (CH3 ethyl), 24.0 (CH2 ethyl), 27.7 [CH3)3C], 33.3 (C-7), 38.2 (C-8), 57.4 
(C-6), 58.6 (C-3), 72.3 (C-2), 82.8 [CH3)3C], 92.3 (C-8a), 125.8 (C-o), 127.2 (C-m), 127.4 (C-p), 128.6 
(C-o), 128.8 (C-m), 129.4 (C-p), 138.1 (C-i), 138.9 (C-i), 165.0 (NCO), 170.0 (CO);  [α]22D  − 169.5 (c 
1.0, CHCl3); HRMS calcd for [C26H31NO4Se + Na]: 524.1310, found: 524.1312. Lower Rf epimer: IR 
(NaCl) 1662, 1725 cm–1; 1H NMR (CDCl3, 400 MHz, COSY, HETCOR) δ 0.93 (t, J = 7.3 Hz, 3H, CH3 
ethyl), 1.15-1.22 (m, 1H, CH2 ethyl), 1.47 [s, 9H, C(CH3)3], 1.62-1.83 (m, 2H, CH2 ethyl, H-8), 1.79 (d, 
J = 12.0 Hz, 1H, H-7), 2.39 (d, J = 12.0 Hz, 1H, H-7), 3.78 (dd, J = 8.8, 6.8 Hz, 1H, H-2), 4.28 (d, J = 
8.0 Hz, 1H, H-8a), 4.37 (dd, J = 8.8, 7.6 Hz, 1H, H-2), 5.31 (t, J = 7.3 Hz, 1H, H-3), 7.11-7.37 (m, 9H, 
ArH), 7.50 (dd, J = 8.0, 1.2 Hz, 1H, ArH); 13C NMR (CDCl3, 100.6 MHz) δ 10.8 (CH3 ethyl), 23.9 (CH2 
ethyl), 27.7 [CH3)3C], 35.3 (C-7), 39.4 (C-8), 55.8 (C-6), 59.0 (C-3), 72.1 (C-2), 83.2 [CH3)3C], 92.0 
(C-8a), 126.5 (C-o), 126.8 (C-m), 127.5 (C-p), 128.6 (C-o), 128.7 (C-m), 129.1 (C-p), 138.0 (C-i), 138.9 
(C-i), 165.5 (NCO), 169.1 (CO); [α]22D  −13.1 (c 0.5, CHCl3). Operating as described above for the 
preparation of compound 11a, unstable lactam 11b (1,78 g) was obtained from the corresponding 
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selenides (2.6 g, 5.2 mmol) in CH2Cl2 (100 mL): 
1H NMR (CDCl3, 400 MHz) δ 1.11 (t, J = 7.3 Hz, 3H, 
CH3 ethyl), 1.50 [s, 9H, C(CH3)3], 1.56-1.65 (m, 1H, CH2 ethyl), 1.82-1.89 (m, 1H, CH2 ethyl), 2.53 
(dddd, J = 9.6, 8.0, 5.2, 2.0 Hz, 1H, H-8), 3.93 (dd, J = 9.2, 6.0 Hz, 1H, H-2), 4.43 (dd, J = 9.2, 7.2 Hz, 
1H, H-2), 5.10 (d, J = 9.6 Hz, 1H, H-8a), 5.27 (t, J = 6.3 Hz, 1H, H-3), 6.98 (d, J = 2.0 Hz, 1H, H-7), 
7.24-7.91 (m, 5H, ArH); 13C NMR (CDCl3, 100.6 MHz) δ 11.0 (CH3 ethyl), 23.5 (CH2 ethyl), 28.0 
[C(CH3)3], 42.4 (C-8), 58.3 (C-3), 73.1 (C-2), 82.0 [C(CH3)3], 90.7 (C-8a), 126.3 (C-o), 127.7 (C-p), 
128.7 (C-m), 131.5 (C-6), 138.9 (C-i), 144.7 (C-7), 157.8 (NCO), 162.5 (CO). 
(3R,7R,8S,8aR)-6-(tert-Butoxycarbonyl)-8-ethyl-5-oxo-3-phenyl-7-vinyl-2,3,6,7,8,8a-hexahydro-
5H-oxazolo[3,2-a]pyridine (12a). Operating as in the above preparation of 2,  rom LiCl (1.23 g, 29.29 
mmol), CuI (5.54 g, 29.08 mmol), vinylmagnesium bromide (1 M in THF, 29.08 mL), TMSCl (3.7 mL, 
29.1 mmol), and a solution of the crude unsaturated lactam 11a (2.5 g, 7.27 mmol) in THF (100 mL), 
lactam 12a was obtained as a mixture of C-6 epimers (ratio 77:23, 2.51 g, 83% overall yield from 10a) 
after flash chromatography (9:1 hexane−EtOAc to 4:1 hexane−EtOAc).  Higher Rf epimer: IR (NaCl) 
1666, 1731 cm–1; 1H NMR (CDCl3, 400 MHz, COSY, HETCOR) δ 1.07 (t, J = 7.2 Hz, 3H, CH3 ethyl), 
1.37 [s, 9H, C(CH3)3], 1.45 (m, 1H, CH2 ethyl), 1.83 (m, 1H, CH2 ethyl), 2.36 (m, 1H, H-8), 3.05 (dd, J 
= 8.0, 3.6 Hz, 1H, H-7), 3.32 (d, J = 0.8 Hz, 1H, H-6), 3.98 (dd, J = 9.2, 1.2 Hz, 1H, H-2), 4.11 (dd, J = 
9.2, 7.2 Hz, 1H, H-2), 4.52 (d, J = 10.0 Hz, 1H, H-8a), 4.90 (dd, J = 7.2, 1.2 Hz, 1H, H-3), 5.16 (d, J = 
17.2 Hz, 1H, HC=CH2), 5.23 (d, J = 10.8 Hz, 1H, HC=CH2), 5.82 (ddd, J = 17.2, 10.8, 8.0 Hz, 1H, 
HC=CH2), 7.20-7.35 (m, 5H, ArH);  
13C NMR (CDCl3, 100.6 MHz) δ 11.0 (CH3 ethyl), 20.5 (CH2 
ethyl), 27.8 [C(CH3)3], 40.6 (C-8), 40.8 (C-7), 53.6 (C-6), 59.4 (C-3), 74.0 (C-2), 81.9 [C(CH3)3], 90.1 
(C-8a), 118.0 (HC=CH2), 126.4, 128.3 (C-o, m), 127.3 (C-p), 134.6 (HC=CH2), 140.9 (C-i), 162.4 
(NCO), 168.6 (COO). Lower Rf epimer:
 1H NMR (CDCl3, 400 MHz, COSY, HETCOR) δ 1.04 (t, J = 
7.6 Hz, 3H, CH3 ethyl), 1.38 [s, 9H, C(CH3)3], 1.45 (bs, 1H, CH2 ethyl), 1.83 (bs, 2H, CH2 ethyl, H-8), 
3.08 (dd, J = 6.0, 3.2 Hz, 1H, H-7), 3.36 (d, J = 6.0 Hz, 1H, H-6), 4.02 (dd, J = 9.2, 0.8 Hz, 1H, H-2), 
4.13 (dd, J = 9.2, 8.8 Hz, 1H, H-2), 4.66 (d, J = 9.2 Hz, 1H, H-8a), 4.92 (bs, 1H, H-3), 5.21 (bs, 2H, 
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HC=CH2), 5.76 (dt, J = 16.8, 10.8 Hz, 1H; HC=CH2), 7.20-7.35 (m, 5H, ArH); 
13C NMR (CDCl3, 100.6 
MHz) δ 10.9 (CH3 ethyl), 20.9 (CH2 ethyl), 28.0 [C(CH3)3], 42.4 (C-7), 44.6 (C-8), 54.6 (C-6), 59.7 (C-
3), 73.7 (C-2), 81.5 [C(CH3)3], 89.6 (C-8a), 119.6 (HC=CH2), 126.5 (C-o), 127.4 (C-m), 127.5 (C-p), 
132.9 (HC=CH2), 141.2 (C-i), 162.9 (COO), 167.7 (NCO). Anal. Calcd. For C22H29NO4
.1/2H2O: C, 
69.45; H, 7.95; N, 3.68. Found C, 69.35; H, 7.93; N, 3.73. 
(3R,7S,8R,8aS)-6-(tert-Butoxycarbonyl)-8-ethyl-5-oxo-3-phenyl-7-vinyl-2,3,6,7,8,8a-hexahydro-
5H-oxazolo[3,2-a]pyridine (12b). Operating as in the above preparation of 12a, from LiCl (0.88 g, 20.8 
mmol), CuI (3.95 g, 20.8 mmol), vinylmagnesium bromide (1 M in THF, 20.8 mL), TMSCl (2.7 mL, 
20.8 mmol), and a solution of the crude unsaturated lactam 11b (1.78 g, 5.2 mmol) in THF (100 mL), 
lactam 12b was obtained as a mixture of C-6 epimers (ratio 4:1, 1.98 g, 84% overall yield from 10b) 
after flash chromatography (hexane to 1:9 hexane−EtOAc). Pure isomers were isolated after a 
subsequent chromatography. Higher Rf epimer: 
1H NMR (CDCl3, 400 MHz, COSY, HETCOR) δ  1.01 
(t, J = 7.3 Hz, 3H, CH3 ethyl), 1.36-1.64 (m, 1H, CH2 ethyl), 1.47 [s, 9H, (CH3)3C], 1.70-1.80 (m, 1H, 
CH2 ethyl), 2.02-2.09 (m, 1H, H-8), 2.97 (ddd, J = 8.0, 3.6, 1.2 Hz, 1H, H-7), 3.45 (d, J = 1.2 Hz, 1H, 
H-6), 3.70 (dd, J = 13.6, 9.0 Hz, 1H, H-2), 4.51 (dd, J = 13.6, 8.4 Hz, 1H, H-2), 4.63 (d, J = 8.8 Hz, 1H, 
H-8a), 5.20-5.30 (m, 3H, H-3, HC=CH2), 5.79-5.90 (m, 1H, HC=CH2), 7.20-7.35 (m, 5H, Ar-H); 
13C 
NMR (CDCl3, 100.6 MHz) δ 11.1 (CH3 ethyl), 21.2 (CH2 ethyl), 27.8 [(CH3)3C], 40.8 (C-8), 41.0 (C-7), 
53.4 (C-6), 58.7 (C-3), 72.5 (C-2), 82.0 [(CH3)3C], 90.5 (C-8a), 118.1 (HC=CH2), 125.8 (C-o), 127.4 
(C-m), 128.7 (C-p), 134.3 (HC=CH2), 139.4 (C-i), 164.2 (NCO), 169.2 (CO); HRMS calcd for 
[C22H29NO4 + H]: 372.2169, found: 372.2166. Lower Rf epimer: 
1H NMR (CDCl3, 400 MHz, COSY, 
HETCOR) δ 1.03 (t, J = 7.4 Hz, 3H, CH3 ethyl), 1.36-1.64 (m, 1H, CH2 ethyl), 1.42 [s, 9H, (CH3)3C], 
1.70-1.80 (m, 1H, CH2 ethyl), 2.02-2.09 (m, 1H, H-8), 3.06 (ddd, J = 10.8, 6.0, 3.2 Hz, 1H, H-7), 3.48 
(d, J = 6.0 Hz, 1H, H-6), 3.69 (t, J = 8.5 Hz, 1H, H-2), 4.53 (dd, J = 8.5, 4.8 Hz, 1H, H-2), 4.66 (d, J = 
9.2 Hz, 1H, H-8a), 5.19 (t, J = 1.2 Hz, 1H, H-3), 5.20-5.37 (m, 2H, HC=CH2), 5.79-5.90 (m, 1H, 
HC=CH2), 7.20-7.35 (m, 5H, Ar-H); 
13C NMR (CDCl3, 100.6 MHz) δ 11.0 (CH3 ethyl), 21.6 (CH2 
 
21 
ethyl), 27.9 [(CH3)3C], 42.2 (C-8), 44.4 (C-7), 54.6 (C-6), 58.1 (C-3), 72.2 (C-2), 81.7 [(CH3)3C], 90.4 
(C-8a), 120.2 (HC=CH2), 125.4 (C-o), 127.3 (C-m), 128.7 (C-p), 132.4 (HC=CH2), 139.0 (C-i), 164.9 
(NCO), 167.7 (CO); HRMS calcd for [C44H58N2O8 + Na]: 765.4085, found: 765.4080. 
 (3R,6R,7R,8S,8aR)-6-[(1-Benzenesulfonyl-2-formyl-3-indolyl)methyl]-6-(tert-butoxycarbonyl)-8-
ethyl-5-oxo-3-phenyl-7-vinyl-2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine (13a). Operating as 
described above for the preparation of 4, rom lactam 12a (500 mg, 1.35 mmol), NaH (60% dispersion 
in mineral oil, 65 mg, 1.62 mmol), and formylindole 6 (2.55 mg, 6.76 mmol) in DMF (60 mL), 
compound 13a (827 mg, 92% yield) was obtained after flash chromatography (9:1 hexane−EtOAc): IR 
(film) 1658, 1736 cm–1; 1H NMR (400 MHz, CDCl3, COSY, HETCOR) δ 0.85 (t, J = 7.4 Hz, 3H, CH3 
ethyl), 1.26-1.47 (m, 2H, CH2 ethyl, H-8), 1.38 [s, 9H, C(CH3)3], 1.62-1.69 (m, 1H, CH2 ethyl), 3.65-
3.74 (m, 3H, CH2-ind, H-7), 3.85 (d, J = 8.8 Hz, 1H, H-2), 4.04 (dd, J = 8.8, 6.4 Hz, 1H, H-2), 4.69 (d, J 
= 9.6 Hz, 1H, H-8a), 4.79 (d, J = 6.4 Hz, 1H, H-3), 5.20 (dd, J = 10.4, 1.6 Hz, 1H, HC=CH2), 5.44 (dd, J 
= 16.8, 1.6 Hz, 1H, HC=CH2), 5.83 (dt, J = 16.8, 10.4 Hz, 1H, HC=CH2), 6.69 (t, J = 7.6 Hz, 1 H, H-5 
ind), 6.78-6.83 (m, 3H, ArH, H-7 ind), 7.05 (ddd, J = 8.8, 6.0, 2.4 Hz, 1H, H-6 ind), 7.26-7.82 (m, 7H, 
ArH), 8.01 (d, J = 8.4 Hz, 1H, H-4 ind), 10.32 (s, 1H, CHO);  13C NMR (CDCl3, 100.6 MHz) δ 10.5 
(CH3 ethyl), 20.3 (CH2 ethyl), 27.9 [(CH3)3C], 31.1 (CH2-ind), 43.0 (C-8), 44.8 (C-7), 60.0 (C-6), 60.2 
(C-3), 74.2 (C-2), 82.4 [(CH3)3C], 88.9 (C-8a), 114.2 (C-7 ind), 120.3 (HC=H2), 124.2 (C-6 ind), 
124.8 (C-5 ind), 126.4 (C-o), 126.7 (C-m), 127.2 (C-p), 128.2 (C-o), 128.8 (C-p), 129.4 (C-m), 130.0 
(C-3 ind), 131.2 (C-2 ind), 133.5 (HC=CH2), 134.2 (C-4 ind), 135.0 (C-3a ind), 137.1 (C-ipso), 137.9 
(C-7a ind), 141.2 (C-ipso), 166.3 (COO), 169.6 (NCO), 183.7 (CHO); [α]22 +19.2 (c 1.0, CHCl3). Anal. 
Calcd. For C38H40N2O7S: C, 68.24; H, 6.03; N, 4.19. Found: C, 67.85; H, 5.97; N, 3.76. 
 (3R,6S,7S,8R,8aS)-6-[(1-Benzenosulfonyl-2-formyl-3-indolyl)methyl]-6-(tert-butoxycarbonyl)-8-
ethyl-5-oxo-3-phenyl-7-vinyl-2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine (13b). Operating as 
described for the preparation of 13a, pure compound 13b (680 g, 75% yield) was obtained from the 
mixture of lactams 12b and 6-epi-12b (500 mg, 1.35 mmol), NaH (65 mg, 1.62 mmol), and 
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formylindole 6 (1.02 g, 2.70 mmol) in DMF (45 mL) after flash chromatography (9:1 hexane−EtOAc to 
1:1 hexane−EtOAc). 13b: IR (KBr) 1671, 1727 cm–1; 1H NMR (400 MHz, CDCl3, COSY, HETCOR) δ 
0.87 (t, J = 7.3 Hz, 3H, CH3 ethyl), 1.22 [s, 9H, (CH3)3C], 1.27-1.37 (m, 1H, CH2 ethyl), 1.68-1.74 (m, 
1H, CH2 ethyl),  2.00 (ddd, J = 13.2, 9.0, 3.6 Hz, 1H, H-8), 2.86 (dd, J = 10.0, 3.6 Hz, 1H H-7), 3.66 (t, 
J = 8.4 Hz, 1H, H-2), 3.70 (d, J = 13.2 Hz, 1H, CH2-ind), 3.85 (d, J = 13.2 Hz, 1H, CH2-ind), 4.49 (t, J = 
8.4 Hz, 1H, H-2), 4.68 (d, J = 9.0 Hz, 1H, H-8a), 5.04 (t, J = 8.4 Hz, 1H, H-3), 5.22 (dd, J = 10.0, 1.6 
Hz, 1H, HC=CH2), 5.25 (dd, J = 17.6, 1.6 Hz, 1H, HC=CH2), 5.81 (dt, J = 17.6, 10.0 Hz, 1 H, 
HC=CH2), 7.20-7.30 (m, 7H, ArH, H-7 ind), 7.39 (dd, J = 8.0, 1.2 Hz, 2H, ArH), 7.43 (dd, J = 8.0, 1.2 
Hz, 1H, H-5 ind), 7.74-7.76 (m, 2H, ArH), 8.00 (d, J = 8.0 Hz, 1H, H-6 ind), 8.09 (d, J = 8.8 Hz, 1H, H-
4 ind), 10.52 (s, 1H, CHO); 13C NMR (CDCl3, 100.6 MHz) δ 10.8 (CH3 ethyl), 21.4 (CH2 ethyl), 27.8 
[CH3)3C], 31.5 (CH2-ind), 40.5 (C-8), 48.9 (C-7), 59.1 (C-3), 59.7 (C-6), 72.1 (C-2), 82.5 [(CH3)3C], 
90.4 (C-8a), 115.0 (C-7 ind), 120.6 (HC=H2), 123.9 (C-6 ind), 124.1 (C-5 ind), 125.7 (C-4 ind), 126.8 
(C-o), 127.2 (C-m), 128.4 (C-p), 128.7 (C-o), 129.0 (C-m), 129.9 (C-3 ind), 132.0 (C-2 ind), 132.7 
(HC=CH2), 133.8 (C-p), 134.8 (C-3a ind), 137.3 (C-i), 137.6 (C-7a ind), 139.4 (C-i), 166.0 (NCO), 
170.3 (CO), 184.8 (CHO); [α]22D  –137.7 (c 0.5, CHCl3); HRMS calcd for [C38H40N2O7S + Na]: 
691.2447, found: 691.2448.  
(3R,6R,7R,8S,8aR)-6-[1-(1-Benzenosulfonyl-2-vinyl-3-indolyl)methyl]-6-(tert-butoxycarbonyl)-8-
ethyl-5-oxo-3-phenyl-7-vinyl-2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine (14a).  Operating as 
described for the preparation of 8, vinylindole 14a was obtained (181 mg, 70% yield) from 
methyltriphenylphosphonium bromide (542 mg, 1.52 mmol), KHMDS (0.5 M in toluene, 3.0 mL, 1.52 
mmol), and lactam 13a (259 mg, 0.38 mmol) in THF (30 mL) after column chromatography (9:1 
hexane−CH2Cl2 to 1:1 hexane−CH2Cl2). 14a: IR (film) 1658, 1736 cm–1; 1H NMR (400 MHz, CDCl3, 
COSY, HETCOR) δ 0.57 (t, J = 7.2 Hz, 3H, CH3 ethyl), 1.01-1.16 (m, 2H, CH2 etthyl, H-8), 1.41 (s, 
9H, (CH3)3C), 1.49-1.55 (m, 1H, CH2 ethyl), 2.99 (dd, J = 10.8, 4.8 Hz, 1H, H-7), 3.51 (d, J = 14.8 Hz, 
1H, CH2-ind), 3.63 (d, J = 14.8 Hz, 1H, CH2-ind), 3.97 (dd, J = 9.1, 1.2 Hz, 1H, H-2), 4.05 (dd, J = 9.1, 
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6.6 Hz, 1H, H-2), 4.66 (d, J = 9.6 Hz, 1H, H-8a), 4.83 (dd, J = 6.6, 1.2 Hz, 1H, H-3), 5.09 (dd, J = 6.7, 
1.6 Hz, 1H, CH-CH=CH2), 5.12 (m, 1H, CH-CH=CH2), 5.39 (dd, J = 18.0, 1.6 Hz, 1H, ind-CH=CH2), 
5.53 (dd, J = 11.2, 1.6 Hz, 1H, ind-CH=CH2), 5.75-5.85 (m, 1H, CH-CH=CH2), 6.73 (dd, J = 7.2, 0.8 
Hz, 1 H, H-5 ind), 6.92 (dd, J = 18.0, 11.2 Hz, 1H, ind-CH=CH2), 7.12-7.35 (m, 9 H, ArH, H-ind), 7.44-
7.73 (m, 2H, ArH, H-ind), 8.12 (d, J = 8.4 Hz, 1H, H-4 ind); 13C NMR (CDCl3, 100.6 MHz) δ 10.2 
(CH3 ethyl), 19.6 (CH2 ethyl), 27.9 [(CH3)3C], 28.6 (CH2-ind), 43.9 (C-8), 44.4 (C-7), 60.0 (C-6), 60.3 
(C-3), 74.3 (C-2), 82.2 [(CH3)3C], 88.5 (C-8a), 113.9 (C-7 ind), 117.5 (C-5 ind), 119.5 (CH-CH=CH2), 
121.2 (C-4 ind), 122.7 (ind-CH=CH2), 124.1 (C-6 ind), 124.8 (C-3 ind), 126.7 (C-o), 127.1 (C-m), 127.4 
(C-p), 128.1 (ind-CH=CH2), 128.5 (C-o), 128.9 (C-m), 130.8 (C-2 ind), 133.6 (C-p), 133.8 (CH-
CH=CH2), 135.4 (C-3a ind), 136.9 (C-7a ind), 138.4 (C-i), 141.0 (C-i), 166.9 (NCO), 169.9 (CO); 
[α]22D  –41.8 (c 0.5, CHCl3); HRMS calcd for [C39H42N2O6S + Na]: 689.2662, found: 689.2662.  
 (3R,6S,7S,8R,8aS)-6-[(1-Benzenesulfonyl-2-vinyl-3-indolyl)methyl]-6-(tert-butoxycarbonyl)-8-
ethyl-5-oxo-3-phenyl-7-vinyl-2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine (14b). Operating as 
in the above preparation of 14a, vinylindole 14b was obtained (1.1 g, 76% yield) from 
methyltriphenylphosphonium bromide (1.52 g, 4.27 mmol), KHMDS (0.5 M in toluene, 8.48 mL, 4.24 
mmol) in THF (20 mL), and lactam 13b (1.45 g, 2.17 mmol) in THF (20 mL) after flash 
chromatography (9:1 hexane−EtOAc to 1:1 hexane−EtOAc). 14b: IR (film) 1655, 1729 cm–1; 1H NMR 
(400 MHz, CDCl3, COSY, HETCOR) δ 0.56 (t, J = 7.4 Hz, 3H, CH3 ethyl), 0.97-1.09 (m, 1H, CH2 
ethyl), 1.26-1.38 (m, 2H, CH2 ethyl, H-8), 1.36 [s, 9H, (CH3)3C], 2.73 (dd, J = 11.2, 4.0 Hz, 1H, H-7), 
3.58 (dd, J = 8.4, 7.6 Hz, 1H, H-2), 3.64 (d, J = 14.8 Hz, 1H, CH2-ind), 3.97 (d, J = 14.8 Hz, 1H, CH2-
ind), 4.08 (t, J = 8.4 Hz, 1H, H-2), 4.54 (d, J = 9.2 Hz, 1H, H-8a), 5.09-5.14 (m, 2H, HC=CH2), 5.19 (t, 
J = 7.6 Hz, 1H, H-3), 5.58 (dd, J = 18.0, 1.2 Hz, 1H, ind-HC=CH2), 5.69-5.78 (m, 1H, HC=CH2), 5.77 
(dd, J = 11.6, 1.2 Hz, 1H, ind-HC=CH2), 7.12 (dd, J = 18.0, 11.6 Hz, 1H, ind-HC=CH2), 7.22-7.38 (m, 
10H, ArH), 7.48 (t, J = 7.6 Hz, 1 H, H-7 ind), 7.70 (d, J = 8.0 Hz, 1H, H-5 ind), 7.75 (d, J = 7.6 Hz, 1H, 
H-6 ind),  8.21 (d, J = 8.4 Hz, 1H, H-4 ind); 13C NMR (CDCl3, 100.6 MHz) δ 10.3 (CH3 ethyl), 20.9 
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(CH2 ethyl), 28.0 [C(CH3)3], 30.4 (CH2-ind), 41.6 (C-8), 46.1 (C-7), 59.0 (C-3), 59.3 (C-6), 71.7 (C-2), 
82.6 [C(CH3)3], 89.4 (C-8a), 114.8 (C-7 ind), 118.4 (C-3 ind), 119.7 (HC=CH2), 121.2 (C-4 ind), 122.6 
(ind-HC=CH2), 123.5 (C-5 ind), 125.4 (C-6 ind), 125.9 (C-o), 126.8 (C-m), 127.4 (C-p), 127.6 (C-o), 
128.6 (C-m), 131.1 (C-2 ind), 133.2 (C-p), 133.7 (ind-HC=CH2), 135.7 (C-i), 136.9 (C-3a ind), 138.3 
(C-7a ind), 139.0 (HC=CH2), 168.2 (NCO), 170.3 (CO); [α]22D  +18.6 (c 0.5, CHCl3); HRMS calcd for 
[C39H42N2O6S + Na]: 689.2662, found: 689.2655.  
(3R,6S,7R,8S,8aR)-6-[(1-Benzenesulfonyl-2-vinyl-3-indolyl)methyl]-8-ethyl-5-oxo-3-phenyl-7-
vinyl-2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine (15a). TFA (100 µl, 1.58 mmol) was added 
to a  solution of 14a (260 mg, 0.39 mmol) in CH2Cl2 (50 mL) and the mixture was stirred at room 
temperature for 2 h. Saturated aqueous Na2CO3 was added to the reaction to reach pH 6-7, and the 
aqueous layer was extracted with CH2 l2. The combined organic extracts were dried and concentrated to 
give an oil, which was dissolved in toluene (30 mL). The resulting solution was heated at reflux for 6 h 
and concentrated to dryness. The residue was chromatographed (1:1 hexane−CH2Cl2 to CH2Cl2) to 
afford lactam 15a (178 mg, 81% yield): IR (film) 1655 cm–1; 1H NMR (400 MHz, CDCl3, COSY, 
HETCOR) δ 0.93 (t, J = 7.2 Hz, 3H, CH3 ethyl), 1.22-1.41 (m, 1H, CH2 ethyl), 1.72-1.86 (m, 1H, CH2 
ethyl), 1.94-2.03 (m, 1H, H-8), 2.26 (dd, J = 8.1, 3.6 Hz, 1H, H-7), 2.75 (dd, J = 10.9, 4.2 Hz, 1H, H-6), 
2.95 (dd, J = 14.5, 10.9 Hz, 1H, CH2-ind), 3.01 (dd, J = 14.5, 4.2 Hz, 1H, CH2-ind), 4.00 (dd, J = 9.2, 
1.4 Hz, 1H, H-2), 4.11 (dd, J = 9.2, 6.9 Hz, 1H, H-2), 4.52 (d, J = 9.6 Hz, 1H, H-8a), 4.66 (dt, J = 17.2, 
1.2 Hz, 1H, CHHC=CH2), 4.88 (dd, J = 6.9, 1.4 Hz, 1H, H-3), 4.95 (d, J = 10.5 Hz, 1H, CHHC=CH2), 
5.47 (dd, J = 17.8, 1.7 Hz, 1H, ind-CH=CH2), 5.64 (ddd, J = 17.2, 10.4, 8.1 Hz, 1H, CHHC=CH2), 5.69 
(dd, J = 11.4, 1.7 Hz, 1H, ind-CH=CH2), 7.13 (dd, J = 17.8, 11.4 Hz, 1H, ind-CH=CH2), 7.18-7.55 (m, 
12H, ArH, H-ind), 7.69 (dd, J = 8.4, 1.2 Hz, 1 H, H-6 ind), 8.19 (d, J = 8.4 Hz, 1H, H-4 ind); 13C NMR 
(CDCl3, 100.6 MHz) δ 11.2 (CH3 ethyl), 20.9 (CH2 ethyl), 26.9 (CH2-ind), 39.5 (C-7 and C-8), 46.0 (C-
6), 59.3 (C-3), 73.8 (C-2), 90.3 (C-8a), 115.1 (C-7 ind), 117.4 (CHHC=CH2), 119.8 (C-5 ind), 120.4 
(ind-CH=CH2), 121.0 (C-4 ind), 123.9 (C-6 ind), 125.4 (C-3 ind), 126.2 (C-o), 126.6 (C-m), 127.5 (C-
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p), 127.9 (ind-CH=CH2), 128.6 (C-o), 128.9 (C-m), 130.3 (C-2 ind), 133.6 (C-p), 135.6 (CHHC=CH2), 
135.7 (C-3a ind), 136.2 (C-7a ind), 138.1 (C-i), 141.9 (C-i), 168.9 (NCO);  [α]22D  +145.3 (c 0.3, 
CHCl3); HRMS calcd for [C34H34N2O4S + H]: 567.2312, found: 567.2316.  
(3R,6R,7S,8R,8aS)-6-[(1-Benzenesulfonyl-2-vinyl-3-indolyl)methyl]-8-ethyl-5-oxo-3-phenyl-7-
vinyl-2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine (15b). Operating as above, compounds 15b 
(756 mg, 77% yield) and 6-epi-15b (136 mg, 14% yield) were obtained from lactam 14b (1.15 g, 1.73 
mmol) in CH2Cl2 (150 mL) and TFA (5 mL, 0.06 mol) in toluene (250 mL) after flash chromatography 
(hexane to 9:1 hexane−EtOAc). 15b (6R, major): IR (KBr) 1653 cm–1; 1H NMR (400 MHz, CDCl3, 
COSY, HETCOR) δ 1.12 (t, J = 7.2 Hz, 3H, CH3 ethyl), 1.46-1.56 (m, 1H, CH2 ethyl), 1.87-1.95 (m, 
2H, CH2 ethyl, H-8), 2.45 (dd, J = 8.0, 2.4 Hz, 1H, H-7), 3.06 (dd, J = 12.0, 3.2 Hz, 1H, H-6), 3.23 (dd, 
J = 14.0, 12.0 Hz, 1H, CH2-ind), 3.55 (dd, J = 14.0, 3.2 Hz, 1H, CH2-ind), 3.86 (t, J = 8.5 Hz, 1H, H-2), 
4.69 (t, J = 8.5 Hz, 1H, H-2), 4.81 (d, J = 8.8 Hz, 1H, H-8a), 4.87 (d, J = 16.8 Hz, 1H, HC=CH2), 5.15 
(d, J = 10.4 Hz, 1H, HC=CH2), 5.41 (d, J = 8.5 Hz, 1H, H-3), 5.67 (dd, J = 17.6, 1.5 Hz, 1H, ind-
HC=CH2), 5.84 (dd, J = 11.2, 1.5 Hz, 1H, ind-HC=CH2), 5.82-5.92 (m, 1H, HC=CH2), 7.31 (dd, J = 
17.6, 11.2 Hz, 1H, ind-HC=CH2), 7.38-7.54 (m, 9H, ArH, H-7 ind), 7.63-7.67 (m, 2H, ArH), 7.79 (d, J 
= 8.0 Hz, 1H, H-5 ind), 7.90 (dd, J = 8.0, 1.2 Hz, 1H, H-6 ind), 8.40 (d, J = 8.4 Hz, 1H, H-4 ind); 13C 
NMR (CDCl3, 100.6 MHz) δ 11.4 (CH3 ethyl), 21.7 (CH2 ethyl), 26.1 (CH2-ind), 39.3 (C-7), 40.0 (C-8), 
45.7 (C-6), 58.9 (C-3), 72.8 (C-2), 90.9 (C-8a), 115.  (C-7 ind), 117.5 (HC=CH2), 119.8 (C-6 ind), 
120.6 (C-2 ind), 121.2 (ind-HC=CH2), 123.9 (C-4 ind), 125.4 (C-5 ind), 126.0 (C-o), 126.6 (C-m), 127.6 
(ind-HC=CH2), 127.8 (C-p), 128.9 (C-o), 128.9 (C-m), 130.3 (C-3 ind), 133.6 (C-p), 135.5 (HC=CH2), 
135.8 (C-3a ind), 136.2 (C-7a ind), 138.1 (C-i), 139.6 (C-i), 170.2 (NCO); [α]22D  –96.0 (c 0.5, CHCl3); 
HRMS calcd for [C34H34N2O4S + H]: 567.2312, found: 567.2316. 6-epi-15b (6S, minor): IR (KBr) 1656 
cm–1; 1H NMR (400 MHz, CDCl3, COSY, HETCOR) δ 0.85 (t, J = 7.3 Hz, 3H, CH3 ethyl), 1.24-1.36 
(m, 1H, CH2 ethyl), 1.48-1.64 (m, 2H, CH2 ethyl, H-8), 2.30 (dt, J = 6.4, 3.6 Hz, 1H, H-7), 2.83 (m, 1H, 
CH2-ind), 2.90 (dd, J = 12.4, 4.4 Hz, 1H, H-6), 3.59 (d,  J = 13.2 Hz, 1H, CH2-ind), 3.71 (t, J = 8.5 Hz, 
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1H, H-2), 4.52 (t, J = 8.5 Hz, 1H, H-2), 4.62 (d, J = 8.8 Hz, 1H, H-8a), 4.98 (dd, J = 17.0, 1.4 Hz, 1H, 
HC=CH2), 5.26 (t, J = 8.5 Hz, 1H, H-3), 5.32 (dd, J = 10.0, 1.4 Hz, 1H, HC=CH2), 5.39 (dd, J = 17.8, 
1.6 Hz, 1H, ind-CH=CH2), 5.55 (dd, J = 11.4, 1.6 Hz, 1H, ind-CH=CH2), 5.62 (dt, J = 17.0, 10.0 Hz, 
1H, HC=CH2), 7.04 (dd, J = 17.8, 11.4 Hz, 1H, ind-CH=CH2), 7.22 (dt, J = 8.0, 1.2 Hz, 1H, H-7 ind), 
7.25-7.39 (m, 9H, ArH), 7.47 (dt, J = 7.2, 1.2 Hz, 1H, H-5 ind), 7.57 (d, J = 8.0 Hz, 2H, ArH), 7.72 (dd, 
J = 8.0, 1.2 Hz, 1H, H-6 ind), 8.21 (d, J = 8.4 Hz, 1H, H-6 ind); 13C NMR (CDCl3, 100.6 MHz) δ 11.4 
(CH3 ethyl), 22.7 (CH2 ethyl), 23.0 (CH2-ind), 42.1 (C-7), 44.9 (C-8), 47.1 (C-6), 58.9 (C-3), 73.0 (C-2), 
91.6 (C-8a), 115.0 (C-7 ind), 119.9 (C-4 ind), 120.8 (C-3 ind), 121.4 (CH2=CH), 122.0 (ind-CH=CH2), 
123.6 (C-5 ind), 125.1 (C-6 ind), 126.0 (C-o), 126.7 (C-m), 127.6 (C-p), 127.7 (C-p), 128.8 (C-o), 128.9 
(C-m), 130.6 (C-2 ind), 132.9 (HC=CH2), 133.5 (ind-CH=CH2), 135.6 (C-i), 136.2 (C-i), 138.2 (C-3a 
ind), 140.0 (C-7a ind), 167.0 (NCO); [α]22D  –16.0 (c 0.2, CHCl3); HRMS calcd for [C34H34N2O4S + 
Na]: 589.2131, found: 589.2132. 
(1R,3aR,4S,4aR,12aS)-7-(Benzenesulfonyl)-4-ethyl-13-oxo-1-phenyl-1,2,3a,4,4a,12,12a,13-
octahydrooxazolo[2”,3”:6’,1’]pyrido[3’,4’:4,5]cyclo hepta[1,2-b]indole (16a). Operating as described 
for the preparation of 5, pentacycle 16a was obtained (31 mg, 86% yield) from compound 15a (38 mg, 
0.07 mmol) and the second−generation Grubbs catalyst (12 mg; 1.7 mg/day, 7 days) in toluene (25 mL) 
after column chromatography (CH2Cl2): IR (KBr) 1655 cm
–1; 1H NMR (400 MHz, CDCl3, COSY, 
HETCOR) δ 0.99 (t, J = 7.2 Hz, 3H, CH3 ethyl), 1.62-1.76 (m, 2H, CH2 ethyl), 2.12 (q, J = 8.0 Hz, 1H, 
H-4), 2.50 (ddd, J = 12.4, 8.4, 4.0 Hz, 1H, H-12a), 2.78 (dd, J = 17.6, 12.0 Hz, 1H, H-12), 2.79-2.85 (m, 
1H, H-4a), 3.45 (dd, J = 17.6, 4.0 Hz, 1H, H-12), 4.15 (dd, J = 9.2, 1.2 Hz, 1H, H-2), 4.24 (dd, J = 9.2, 
6.4 Hz, 1H, H-2), 4.78 (d, J = 8.0 Hz, 1H, H-3a), 4.93 (d, J = 6.1 Hz, 1H, H-1), 6.18 (dd, J = 12.0, 6.0 
Hz, 1H, H-5), 7.19-7.41 (m, 12H, ArH, H-6, H-10), 7.46 (tt, J = 7.5, 1.2 Hz, 1H, H-9), 7.66 (dd, J = 8.4, 
1.2 Hz, 1H,  H-8), 8.24 (d, J = 8.4 Hz, 1H, H-11); 13C NMR (CDCl3, 100.6 MHz) δ 11.5 (CH3 ethyl), 
20.5 (CH2 ethyl), 25.2 (C-12), 40.2 (C-4), 44.9 (C-4a), 45.2 (C-12a), 58.9 (C-1), 74.4 (C-2), 90.3 (C-3a), 
115.6 (C-8), 118.8 (C-9), 120.3 (C-11), 123.6 (C-6a), 124.2 (C-10), 125.6 (C-11a), 126.2 (C-11b), 126.5 
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(C-o), 126.8 (C-m), 127.7 (C-p), 128.6 (C-o), 128.8 (C-m), 131.0 (C-11a), 132.5 (C-5), 133.5 (C-p), 
136.8 (C-7a), 138.1 (C-i), 141.0 (C-i), 168.5 (NCO); mp 195−144 ºC (CH3Cl, hexane); [α]22D  +73.4 (c 
0.2, CHCl3). Anal. Calcd. For C32H30N2O4S
.1/4CHCl3: C, 68.14; H, 5.36; N, 4.93. Found C, 67.88; H, 
5.60; N, 4.59. 
(1R,3aS,4R,4aS,12aR)-7-Benzenesulfonyl-4-ethyl-13-oxo-1-phenyl-1,2,3a,4,4a,12,12a,13-
octahydrooxazolo[2”,3”:6’,1’]pyrido[3’,4’:4,5]cyclo hepta[1,2-b]indole (16b). Operating as described 
in the above preparation of 16a, pentacycle 16b was obtained (1.09 g, 87% yield) from lactam 15b (1.31 
g, 2.32 mmol) and the second−generation Grubbs catalyst (265 mg; 53 mg/day, 5 days) in toluene (300 
mL) after flash chromatography (hexane to 1:1 hexan−EtOAc): IR (KBr) 1656 cm–1; 1H NMR (400 
MHz, CDCl3, COSY, HETCOR) δ 0.99 (t, J = 7.4 Hz, 3H, CH3 ethyl), 1.53-1.64 (m, 2H, CH2 ethyl), 
1.89-1.95 (m, 1H, H-4), 2.62 (dt, J = 10.0, 3.6 Hz, 1H, H-12a), 2.77 (ddd, J = 10.0, 5.4, 2.1 Hz, 1H, H-
4a), 2.87 (dd, J = 16.8, 10.0 Hz, 1H, H-12), 3.46 (dd, J = 16.8, 3.6 Hz, 1H, H-12), 3.84 (dd, J = 9.0, 6.6 
Hz, 1H, H-2), 4.40 (dd, J = 9.0, 7.8 Hz, 1H, H-2), 4.92 (d, J = 4.8 Hz, 1H, H-3a), 5.31 (t, J = 6.9 Hz, 1H, 
H-1), 6.10 (dd, J = 11.7, 5.1 Hz, 1H, H-5), 7.23-7.50 (m, 13H, ArH, -6, H-9, H-10), 7.66 (dd, J = 8.4, 
1.2 Hz, 1H, H-8), 8.24 (d, J = 8.1 Hz, 1H, H-11); 13C NMR (CDCl3, 100.6 MHz) δ 12.1 (CH3 ethyl), 
19.9 (CH2 ethyl), 24.3 (C-12), 39.8 (C-4a), 43.8 (C-4), 44.3 (C-12a), 58.6 (C-1), 71.8 (C-2), 90.2 (C-3a), 
115.5 (C-8), 118.9 (C-9), 121.1 (C-6a), 123.8 (C-11), 24.1 (C-10), 125.5 (C-11a), 126.1 (C-11b), 126.4 
(C-o), 127.6 (C-m), 128.7 (C-p), 128.8 (C-o), 130.8 (C-6), 132.6 (C-5), 132.8 (C-m), 133.5 (C-p), 136.7 
(C-i), 137.9 (C-7a), 139.4 (C-i), 170.8 (NCO); mp 161−163ºC (MeOH); [α]22D –244.0 (c 0.3, CHCl3). 
Anal. Calcd. For C32H30N2O4S
.1/2H2O: C, 70.57; H, 5.67; N, 5.14; S, 5.89. Found C, 70.53; H, 5.74; N, 
5.09; S, 5.89. 
RCM reaction from 6-epi-15b.  Operating as in the preparation of compound 5, pentacycle 6-epi-16b 
(240 mg, 24% yield) and hexacycle 21 (540 mg, 50% yield) were obtained from diene 6-pi-15b (1.08 
g, 1.91 mmol) and the second−generation Grubbs catalyst (480 mg; 30 mg/day, 16 days) in toluene (500 
mL) after flash chromatography (9:1 hexane−EtOAc to 4:1 hexane−EtOAc). 16-epi-16b: IR (film) 1655 
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cm–1; 1H NMR (400 MHz, CDCl3, COSY, HETCOR) δ 0.97 (t, J = 7.4 Hz, 3H, CH3 ethyl), 1.46-1.73 
(m, 2H, CH2 ethyl), 1.89 (ddd, J = 14.0, 7.6, 5.2 Hz, 1H, H-4), 2.89-2.95 (m, 1H, H-4a), 2.92 (dd, J = 
14.4, 10.4 Hz, 1H, H-12), 3.18 (dd, J = 14.4, 5.2 Hz, 1H, H-12), 3.31 (dt, J = 7.2, 5.2 Hz, 1H, H-12a), 
3.63 (dd, J = 8.8, 8.4 Hz, 1H, H-2), 4.50 (dd, J = 8.8, 8.4 Hz, 1H, H-2), 4.78 (d, J = 9.2 Hz, 1H, H-3a), 
5.20 (t,  J = 8.0 Hz, 1H, H-1), 6.21 (dd, J = 11.6, 5.2 Hz, 1H, H-5), 6.88-7.79 (m, 14H, ArH, -6, H-8, 
H-9, H-10), 8.20 (d, J = 8.4 Hz, 1H, H-11); 13C NMR (CDCl3, 100.6 MHz) δ 11.4 (CH3 ethyl), 22.1 
(CH2 ethyl), 25.4 (C-12), 38.6 (C-4a), 43.6 (C-4), 54.2 (C-12a), 58.3 (C-1), 72.6 (C-2), 90.7 (C-3a), 
114.6 (C-8), 119.1 (C-9), 123.0 (C-6a), 124.0 (C-11), 24.2 (C-10), 125.2 (C-o), 125.3 (C-p), 126.5 (C-
m), 127.0 (C-11a), 127.3 (C-11b), 128.7 (C-o), 129.2 (C-m), 130.1 (C-p), 130.6 (C-6), 133.6 (C-5), 
136.2 (C-7a ind), 138.7 (C-i), 138.8 (C-i), 169.9 (NCO); [α]22D –252.0 (c 0.3, CHCl3); HRMS calcd for 
[C32H30N2O4S + H]: 539.1999, found: 539.1997. 21: IR (film) 1655 cm
–1; 1H NMR (400 MHz, CDCl3, 
COSY, HETCOR; see Supporting Information for the numbering system) δ 1.02 (dd, J = 13.2, 8.4 Hz, 
1H, H-15), 1.10 (t, J = 7.4 Hz, 3H, CH3 ethyl), 1.25-1.33 (m, 1H, H-15), 1.30 (d, J = 13.2 Hz, 1H, H-8), 
1.56-1.69 (m, 1H, CH2 ethyl), 1.71 (d, J = 13.2 Hz, 1H, H-8), 1.84 (ddd, J = 13.2, 9.2, 4.0 Hz, 1H,  H-
9), 1.99 (ddd, J = 13.6, 8.4, 2.4 Hz, 1H, CH2 ethyl), 2.04 (dt, J = 13.2, 2.8 Hz, 1H, H-7), 2.17 (dt, J = 
12.4, 2.8 Hz, 1H, H-7), 2.39 (t, J = 8.4 Hz, 1H, H-14a), 2.50 (ddd, J = 10.4, 6.0, 3.6 Hz, 1H, H-8b), 2.57 
(dd, J = 10.4, 6.0 Hz, 1H, H-8a), 4.14 (dd, J = 9.2, 6.8 Hz, 1H, H-11), 4.44 (dd, J = 9.2, 8.0 Hz, 1H, H-
11), 5.18 (d, J = 8.4 Hz, 1H, H-9a), 5.27 (t, J = 7.4 Hz, 1H, H-12), 6.03 (dt, J = 7.2, 0.8 Hz, 1H, H-1), 
6.30 (dd, J = 8.0, 0.8 Hz, 1H, H-2), 6.35 (dd, J = 8.4, 2.8 Hz, 1H, H-6), 6.95 (dt, J = 8.0, 1.2 Hz, 1H, H-
3), 7.35-7.70 (m, 11H, ArH, H-4); 13C NMR (CDCl3, 100.6 MHz) δ 11.7 (CH3 ethyl), 19.0 (C-7), 22.9 
(CH2 ethyl), 28.3 (C-8), 41.0 (C-8b), 41.5 (C-8a), 42.7 (C-9), 45.7 (C-14a), 47.1 (C-15), 59.5 (C-12), 
71.8 (C-11), 90.3 (C-9a), 114.6 (C-6), 115.3 (C-4), 121.8 (C-2), 124.5 (C-1), 127.0 (C-o), 127.4 (C-p), 
128.2 (C-p), 128.6 (C-m), 128.8 (C-15b), 128.9 (C-o), 129.1 (C-m), 133.4 (C-3), 138.1 (C-4a), 138.4 (C-
5a), 139.0 (C-15a), 139.3 (C-i), 146.7 (C-i), 169.9 (NCO); mp 193–195 ºC (MeOH): [α]22D  –85.5 (c 




decahydrooxazolo[2”,3”:6’,1’]pyrido[3’,4’:4,5]cyclo hepta[1,2-b]indole (dihydro-16b). A solution of 
lactam 16b (500 mg, 0.93 mmol) in EtOAc (15 mL) containing 20% PtO2 (100 mg) was hydrogenated 
at room temperature for 24 h. The catalyst was remov d by filtration and washed with hot MeOH. The 
combined solution was concentrated and the residue was chromatographed (9:1 hexane−EtOAc) to give 
dihydro-16b (360 mg, 72% yield): IR (KBr) 1662 cm–1; 1H NMR (400 MHz, CDCl3, COSY, HETCOR) 
δ 1.00 (t, J = 7.6 Hz, 3H, CH3 ethyl), 1.43-1.62 (m, 2H, CH2 ethyl), 1.75 (ddd, J = 18.0, 9.2, 3.6 Hz, 1H, 
H-5), 1.87-1.95 (m, 2H, H-4, H-5), 2.08-2.16 (m, 1H, -4a), 2.57 (ddd, J = 11.2, 8.4, 4.0 Hz, 1H, H-
12a), 2.87 (dd, J = 16.0, 8.4 Hz, 1H, H-12), 3.21 (ddd, J = 17.2, 9.2, 4.4 Hz, 1H, H-6), 3.41-3.50 (m, 1H, 
H-6), 3.43 (dd, J = 16.0, 4.0 Hz, 1H, H-12), 3.78 (dd, J = 9.2, 7.2 Hz, 1H, H-2), 4.38 (t, J = 8.4 Hz, 1H, 
H-2), 4.74 (d, J = 2.8 Hz, 1H, H-3a), 5.36 (t, J = 7.4 Hz, 1H, H-1), 7.23-7.55 (m, 11H, ArH, H-8, H-9, 
H-10), 7.70 (dd,  J = 8.8, 1.2 Hz, 2H, ArH), 8.19 (dd, J = 6.4, 1.6 Hz, 1H, H-11); 13C NMR (CDCl3, 
100.6 MHz) δ 12.6 (CH3 ethyl), 19.6 (CH2 ethyl), 22.2 (C-12), 25.3 (C-6), 28.1 (C-5), 37.6 (C-4a), 41.2 
(C-12a), 44.6 (C-4), 58.5 (C-1), 71.4 (C-2), 89.8 (C-3a), 114.8 (C-8), 118.5 (C-9), 119.5 (C-6a), 123.6 
(C-10), 124.2 (C-11), 126.0 (C-o), 126.2 (C-m), 127.6 (C-p), 128.8 (C-o), 129.2 (C-m), 130.7 (C-11b), 
133.5 (C-p), 136.4 (C-11a), 136.6 (C-7a), 139.2 (C-i), 139.9 (C-i), 172.1 (NCO); [α]22D  –22.5 (c 1.0, 
CHCl3); HRMS calcd for [C32H32N2O4S + H]: 541.2155, found: 541.2160. Anal. Calcd. For 
C32H32N2O4S
.1/3CHCl3: C, 66.94; H, 5.62; N, 4.83; S, 5.53. Found C, 66.57; H, 5.81; N, 4.58; S, 5.13. 
(4R,4aS,12aR)-7-Benzenesulfonyl-4-ethyl-2-[(1R)-2-hydroxy-1-phenylethyl]-1,3,4,4a,5,6,12,12a-
octahydropyrido[3’,4’:4,5]cyclohepta[1,2-b]indole (17). LiAlH 4 (436 mg, 11.5 mmol) was slowly 
added to a suspension of AlCl3 (498 mg, 3.73 mmol) in THF (50 mL) at 0 ºC. After he mixture was 
stirred at 25 ºC for 30 min and cooled to –78 ºC, a solution of dihydro-16b (940 mg, 1.74 mmol) in 
anhydrous THF (10 mL) was slowly added. The stirring was continued at –78 ºC for 10 min and at 0 ºC 
for 1 h 30 min. The reaction was quenched with water. The aqueous layer was extracted with EtOAc, 
and the combined organic extracts were dried and concentrated to give a foam, which was 
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chromatographed (9:1 hexane−EtOAc to 4:1 hexane−EtOAc) to afford compound 17 (805 mg, 88% 
yield): IR (KBr) 3441 cm–1; 1H NMR (400 MHz, CDCl3, COSY, HETCOR) δ 0.90 (t, J = 7.2 Hz, 3H, 
CH3 ethyl), 1.17-1.54 (m, 7H, CH2 ethyl, H-4, H-4a, H-5, H-12a), 2.10 (dd, J = 15.2, 10.8 Hz, 1H, H-3), 
2.28 (d, J = 11.6 Hz, H-12), 2.57 (dd, J = 15.2, 1.6 Hz, 1H, H-3), 2.66 (dd, J = 15.2, 10.8 Hz, 1H, H-6), 
2.85 (d, J = 8.8 Hz, 1H, H-1), 2.95 (d, J = 11.6 Hz, 1H, H-12), 3.62-3.77 (m, 3H, H-6, NCH, CH2O), 
4.01-4.09 (m, 1H, CH2O), 7.19-7.51 (m, 11H, ArH, H-8, H-9, H-10), 7.66 (dd, J = 8.4, 0.8 Hz, 2H, 
ArH), 8.20-8.23 (m, 1H, H-11);  13C NMR (CDCl3, 100.6 MHz) δ 12.7 (CH3 ethyl), 18.8 (CH2 ethyl), 
25.4 (C-12), 28.8 (C-6), 31.5 (C-5), 35.3 (C-4a), 43.7 (C-12a), 49.7 (C-4), 53.4 (C-3), 55.6 (C-1), 60.2 
(CH2O), 70.0 (NCH), 115.3 (C-8), 117.7 (C-9), 121.1 (C-6a), 123.4 (C-10), 123.9 (C-11), 126.2 (C-o), 
127.9 (C-p), 128.2 (C-m), 128.9 (C-o), 129.1 (C-m), 130.4 (C-11b), 133.5 (C-p), 135.2 (C-11a), 136.3 
(C-7a), 139.3 (C-i), 139.6 (C-i); [α]22D  +73.2 (c 0.37,  CHCl3); HRMS calcd for  [C32H36N2O3S + H]:  
529.2519, found: 529.2526. Anal. Calcd. For C32H36N2O3S: C, 72.70; H, 6.86; N, 5.30. Found C, 72.62; 
H, 7.12; N, 5.01.  
(4R,4aS,12aR)-4-Ethyl-2-[(1R)-2-hydroxy-1-phenylethyl]-1,3,4,4a,5,6,12,12a-
octahydropyrido[3’,4’:4,5]cyclohepta[1,2-b]indole (18). Mg turnings (207 mg, 8.50 mmol) were 
added to a solution of compound 17 (805 mg, 1.53 mmol) in anhydrous MeOH (60 mL) at  0 ºC. The 
resulting mixture was warmed to room temperature and vigorously stirred for 4 h. The reaction was 
quenched with water, and the resulting solution was extracted with CH2Cl2. The combined organic 
extracts were washed with saturated aqueous NaCl, dried, and concentrated. The resulting residue was 
chromatographed (hexane to 4:1 hexane−EtOAc) to give the N-unsubstituted indole 18 (480 mg, 81% 
yield): IR (KBr) 3411, 2925 cm–1; 1H NMR (400 MHz, CDCl3, COSY, HETCOR) δ 0.94 (t, J = 7.2 Hz, 
3H, CH3 ethyl), 1.21-1.74 (m, 7H, CH2 ethyl, H-4, H-4a, H-5, H-12a), 2.22 (dd, J = 14.8, 11.2 Hz, 1H, 
H-12), 2.32 (d, J = 12.4 Hz, 1H, H-3), 2.72-2.84 (m, 3H, H-1, H-12), .94-3.01 (m, 2H, H-3, H-6), 2.65-
3.75 (m, 2H, NCH, CH2O), 4.07-4.16 (m, 1H, CH2O), 7.08-7.46 (m, 9H, ArH, H-8, H-9, H-10, H-11), 
7.75 (sa, 1H, NH); 13C NMR (CDCl3, 100.6 MHz) δ 12.8 (CH3 ethyl), 18.8 (CH2 ethyl), 27.9 (C-12), 
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29.4 (C-6), 32.5 (C-5), 36.5 (C-4a), 44.2 (C-12a), 49.4 (C-4), 53.6 (C-3), 55.6 (C-1), 60.3 (CH2O), 70.1 
(NCH), 110.3 (C-8), 110.9 (C-6a), 117.4 (C-9), 119.2 (C-10), 120.6 (C-11), 127.9 (C-11b), 128.2 (C-o), 
128.8 (C-p), 129.0 (C-m), 134.1 (C-11a), 135.3 (C-7a), 138.0 (C-i); [α]22D +8.3 (c 0.29,  CHCl3); HRMS 
calcd for  [C26H32N2O + H]:  389.2594, found: 389.2599. Anal. Calcd. For C26H32N2O
.1/4EtOAc: C, 
78.99; H, 8.35; N, 6.82. Found C, 79.03; H, 8.41; N, 6.67.  
(4R,4aS,12aR)-2-(tert-Butoxycarbonyl)-4-ethyl-1,3,4,4a,5,6,12,12a-
octahydropyrido[3’,4’:4,5]cyclohepta[1,2-b]indole (19). A solution of indole 18 (160 mg, 0.41 mmol) 
and di-tert-butyl dicarbonate (94 mg, 0.43 mmol) in EtOAc (25 mL) containing 30% Pd(OH)2-C (48 
mg) was hydrogenated at rt for 16 h at atmospheric pressure. The catalyst was removed by filtration, and 
the solvent was evaporated to give an oil. Flash chromatography (hexane to 4:1 hexane−EtOAc) 
afforded 19 (91 mg, 60% yield): IR (KBr) 1667 cm–1; 1H NMR (400 MHz, CDCl3, COSY, HETCOR) 
δ 0.94 (t, J = 7.2 Hz, 3H, CH3 ethyl), 1.12-1.45 (m, 3H, CH2 ethyl, H-4), 1.47 [s, 3H, C(CH3)3], 1.60-
1.74 (m, 4H, H-4a, H-5, H-12a), 2.29 (dd, J = 15.2, 10.0 Hz, 1H, H-6), 2.43-2.46 (m, 1H, H-1), 2.70-
2.92 (m, 4H, H-3, H-6, H-12), 4.16 (d, J = 12.4 Hz, 1H, H-3), 4.30 (d, J = 12.0 Hz, 1H, H-1), 7.07-7.09 
(m, 2H, H-9, H-10), 7.24-7.25 (m, 1H, H-8), 7.40-7.4  (m, 1H, H-11), 7.82 (sa, 1H, NH);  13C NMR 
(CDCl3, 100.6 MHz) δ 12.7 (CH3 ethyl), 17.2 (CH2 ethyl), 27.9 (C-3), 28.4 [C(CH3)3], 29.7 (C-5), 32.8 
(C-6), 35.8 (C-4a), 44.2 (C-12a), 46.7 (C-3), 49.7 (C-1), 49.9 (C-3), 79.2 [C(CH3)3], 110.3 (C-8), 110.6 
(C-6a), 117.4 (C-9), 119.2 (C-10), 120.6 (C-11), 128.8 (C-11b), 134.2 (C-11a), 138.0 (C-7a), 155.1 
(NCO); [α]22D –0.4 (c 0.7, CHCl3); HRMS calcd for  [C46H64N4O4 + H]:  737.4844, found: 737.4835. 
 (4R,4aS,12aR)-2-(tert-Butoxycarbonyl)-4-ethyl-6-oxo-1,3,4,4a,5,6,12,12a-
octahydropyrido[3’,4’:4,5]cyclohepta[1,2-b]indole (20). I2O5 (84 mg, 0.25 mmol) was added to a 
solution of compound 19 (78 mg, 0.21 mmol) in THF-H2O (9:1, 10 mL) at 0 ºC, and the mixture was 
stirred at room temperature for 5 h 30 min. The mixture was poured into saturated aqueous NaHCO3, 
and the aqueous layer was extracted with EtOAc. The combined organic extracts were washed with 20% 
aqueous Na2S2O3 and brine, dried, filtered, and concentrated. The resulting oil was chromatographed 
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(CH2Cl2) affording compound 20 (67 mg, 83% yield): IR (KBr) 1692, 1729 cm
–1; 1H NMR (400 MHz, 
CDCl3, COSY, HETCOR) δ 1.00 (t, J = 7.2 Hz, 3H, CH3 ethyl), 1.24-1.34 (m, 2H, CH2 ethyl), 1.46 [s, 
3H, C(CH3)3], 1.60 (m, 1H, H-4), 1.91-2.00 (m, 1H, H-4a), 2.02-2.11 (m, 1H, H-12a), 2.47-2.53 (m, 1H, 
H-1), 2.72-2.87 (m, 2H, H-5), 2.77 (dd, J = 15.6, 7.2 Hz, 1H, H-3), 2.84 (dd, J = 16.4, 4.8 Hz, 1H, H-
12), 3.16 (dd, J = 16.4, 6.0 Hz, 1H, H-12), 4.10 (dd, J = 10.4, 2.8 Hz, 1H, H-3), 4.31 (d, J = 12.0 Hz, 
1H, H-1), 7.16 (ddd, J = 8.0, 6.0, 1.2 Hz, 1H, H-11), 7.33-7.39 (m, 2H, H-9, H-10), 7.64 (d, J = 8.0 Hz, 
1H, H-8), 8.86 (sa, 1H, NH); 13C NMR (CDCl3, 100.6 MHz) δ 12.8 (CH3 ethyl), 17.9 (CH2 ethyl), 26.7 
(C-12), 29.1 [C(CH3)3], 36.2 (C-12a), 42.6 (C-4a), 43.2 (C-4), 46.3 (C-5), 46.8 (C-1), 49.8 (C-3), 79.6 
[C(CH3)3], 112.0 (C-8), 120.4 (C-10), 120.8 (C-11), 123.0 (C-11b), 126.6 (C-9), 127.6 (C-11a), 132.6 
(C-6a), 136.4 (C-7a), 155.5 (NCO), 193.9 (CO); [α]22D –22,9 (c 0.24, CHCl3); HRMS calcd for 
[C23H30N2O3 + H]:  383.2329, found: 383.2329.  
(–)-16-Episilicine. TFA (50 µl, 0.79 mmol) was added to a solution of indole 20 (67 mg, 0.18 mmol) in 
anhydrous CH2Cl2 (10 mL). The mixture was stirred at room temperature for 5 h and brought to pH 7 by 
addition of saturated aqueous NaHCO3. The aqueous layer was extracted with CH2 l2, and the 
combined organic extracts were dried and concentrated to give the corresponding amine, which was 
used in the next reaction without further purificaton. The residue was dissolved in anhydrous CH3 N (5 
mL), MeI (18 µl, 0.29 mmol) was added, and the mixture was stirred at room temperature for 3 h. The 
solution was washed with saturated aqueous NaHCO3, and the aqueous phase was extracted with 
EtOAc. The combined organic extracts were dried, filtered, and concentrated. Flash chromatography 
using a cartridge containing amine functionalized silica (EtOAc to EtOAc−MeOH 4:1) afforded pure 
(−)-16-episilicine (30 mg, 55% yield): 1H NMR (400 MHz, CDCl3, COSY, HETCOR) δ 0.97 (t, J = 7.2 
Hz, 3H, CH3 ethyl), 1.34-1.46 (m, 2H, CH2 ethyl), 1.56-2.02 (m, 5H, H-15, H-20, H-21, H-5), 2.20-2.40 
(m, 1H, H-16), 2.29 (sa, 3H, NCH3), 2.81 (d, J = 6.4 Hz, 2H, H-14), 2.84 (dd, J = 17.2, 4.8 Hz, H-21), 
2.90-3.09 (m, 2H, H-5, H-6), 3.18 (dd, J = 16.4, 6.4 Hz, 1H, H-6), 7.14 (ddd, J = 8.0, 6.8, 1.0 Hz, 1H, 
H-10), 7.33 (ddd, J = 8.0, 6.4, 1.0 Hz, 1H, H-11), 7.37 (d, J = 8.0 Hz, 1H, H-12), 7.65 (d, J = 8.4 Hz, 
1H, H-9), 8.79 (sa, 1H, NH);  13C NMR (CDCl3, 100.6 MHz) δ 12.9 (C-18), 18.9 (C-19), 27.1 (C-6), 
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35.7 (C-16), 41.9 (C-15), 43.0 (C-20), 46.2 (NCH3), 46.8 (C-14), 57.8 (C-21), 63.4 (C-5), 112.1 (C-12), 
120.3 (C-10), 120.7 (C-9), 123.1 (C-7), 126.5 (C-11), 127.7 (C-8), 132.6 (C-2), 136.4 (C-13), 194.3 
(CO); [α]22D  –20,0 (c 1.0, CHCl3). 
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